,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,75233,2406,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,357,2,1,,855531,2406,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
2,361,1,2,,855531,2406,Inactive,285623.0,,,,Pyruvate Kinase,Confirmatory,,
3,364,1,3,,855531,2406,Inactive,,,,,Cell Proliferation & Viability (Cytotoxicity) Assay,Confirmatory,,
4,368,2,3,,855531,2406,Inactive,4757950.0,994.0,,,Cdc25B Catalytic Domain protein tyrosine phosphatase  HTS,Screening,,
5,371,1,1,,855531,2406,Active,,,,,Human A549 Lung Tumor Cell Growth Inhibition Assay,Screening,,
6,373,1,4,,855531,2406,Inactive,38788193.0,1903.0,,,S1P3 Agonist Primary HTS and Confirmation Assays,Screening,,
7,374,2,3,,855531,2406,Inactive,4758204.0,1843.0,,,In vitro Primary HTS Assay for MKP-1,Screening,,
8,375,2,3,,855531,2406,Inactive,90108679.0,,,,Mycobacterium tuberculosis Pantothenate Synthetase Assay,Confirmatory,,
9,411,2,1,,855531,2406,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
10,421,1,3,,17389712,2406,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
11,422,1,5,,855531,2406,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
12,425,3,2,,855531,2406,Inactive,16758752.0,116663.0,,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
13,426,1,2,,17389712,2406,Active,,,,,Cell Viability - Jurkat,Confirmatory,,
14,427,1,1,,17389712,2406,Active,,,,,Cell Viability - Hek293,Confirmatory,,
15,429,1,5,,855531,2406,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
16,429,1,5,,855531,2406,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
17,430,2,4,,855531,2406,Active,,,1.21,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells),Confirmatory,,
18,431,2,4,,855531,2406,Active,,,1.34,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells),Confirmatory,,
19,432,2,4,,855531,2406,Inactive,11024684.0,12044.0,,IC50,HTS discovery of chemical inhibitors of anti-apoptotic protein Bfl-1,Confirmatory,,
20,433,1,1,,17389712,2406,Active,,,,,Cell Viability - HepG2,Confirmatory,,
21,434,1,2,,17389712,2406,Inconclusive,,,,,Cell Viability - MRC5,Confirmatory,,
22,435,1,2,,17389712,2406,Inconclusive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
23,436,2,1,,855531,2406,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
24,438,1,4,,855531,2406,Inactive,223468676.0,5970.0,,,Cellular assay for TNF alpha induced NFkappaB translocation,Screening,,
25,440,3,3,,855531,2406,Inactive,4503779.0,2357.0,,,Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands,Screening,,
26,441,3,3,,855531,2406,Inactive,54112388.0,2358.0,,,Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands,Screening,,
27,444,1,1,,855531,2406,Active,,,,,NFAT Signaling Pathway,Confirmatory,,
28,445,3,1,,17389712,2406,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
29,446,1,1,,855531,2406,Active,,,,,Stat Signaling Pathway,Confirmatory,,
30,449,1,5,,855531,2406,Active,13027636.0,1901.0,,,Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators,Screening,,
31,450,1,2,,855531,2406,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
32,453,2,2,,855531,2406,Inactive,63102437.0,1508.0,,,Cathepsin B,Screening,,
33,454,1,7,,855531,2406,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
34,455,1,7,,855531,2406,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression,Screening,,
35,456,1,7,,855531,2406,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
36,457,1,7,,855531,2406,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression.,Screening,,
37,460,2,2,,855531,2406,Inactive,4503155.0,1514.0,,,Cathepsin L,Screening,,
38,466,1,5,,855531,2406,Active,13027636.0,1901.0,,,Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Potentiator Assay 60K MLSMR,Confirmatory,,
39,467,1,5,,855531,2406,Active,13027636.0,1901.0,,,Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Parental Cell Line Counter Screen 60K MLSMR,Confirmatory,,
40,468,1,5,,855531,2406,Active,13027636.0,1901.0,,,Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR,Confirmatory,,
41,483,1,6,,855531,2406,Inactive,296434520.0,3064.0,,,Aggregation and Clearance of Mutant Huntingtin Protein,Screening,,
42,485,1,8,,855531,2406,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
43,487,1,2,,855531,2406,Inactive,,,,,TNFalpha Induced E-Selectin Expression -  Primary screen,Screening,,
44,488,2,1,,855531,2406,Inactive,63102437.0,1508.0,,,Cathepsin B compound mixture screening,Screening,,
45,501,2,2,,855531,2406,Inactive,23110962.0,1520.0,,,Cathepsin S,Screening,,
46,518,2,6,,855531,2406,Inactive,116734717.0,249.0,,IC50,TNAP luminescent HTS assay,Confirmatory,,
47,521,2,5,,855531,2406,Inactive,18375660.0,5778.0,,IC50,"HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target",Confirmatory,,
48,522,1,2,,855531,2406,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
49,524,1,3,,855531,2406,Inactive,4506055.0,5566.0,,,Primary biochemical high-throughput screening assay for inhibitors of protein kinase A (PKA) activity,Screening,,
50,525,1,3,,855531,2406,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
51,527,3,1,,855531,2406,Inactive,,,,,Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing,Screening,,
52,528,1,4,,855531,2406,Inconclusive,67191027.0,3676.0,,,Allosteric Agonists for the VLA-4 Integrin,Screening,,
53,529,1,4,,855531,2406,Inconclusive,67191027.0,3676.0,,,Allosteric Antagonists for the VLA-4 Integrin,Screening,,
54,530,1,1,,17389712,2406,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
55,538,2,2,,855531,2406,Inactive,4502495.0,716.0,,,Complement factor C1s,Screening,,
56,539,1,2,,855531,2406,Inactive,116077694.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK,Screening,,
57,540,1,1,,17389712,2406,Active,,,,,Cell Viability - N2a,Confirmatory,,
58,541,1,1,,17389712,2406,Inconclusive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
59,542,1,1,,17389712,2406,Active,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
60,543,1,1,,17389712,2406,Active,,,,,Cell Viability - H-4-II-E,Confirmatory,,
61,544,2,1,,17389712,2406,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
62,545,1,1,,17389712,2406,Inconclusive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
63,546,1,1,,17389712,2406,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
64,552,1,3,,855531,2406,Inactive,,,,,Antimicrobial HTS Assay for E. coli BW25113 (wild type),Screening,,
65,555,1,2,,855531,2406,Inactive,116516899.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK,Screening,,
66,556,1,3,,855531,2406,Inactive,116076351.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC,Screening,,
67,559,2,2,,855531,2406,Inactive,147728.0,,,,RNA polymerase,Screening,,
68,560,1,2,,855531,2406,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
69,561,1,3,,855531,2406,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
70,565,1,4,,855531,2406,Inactive,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605,Screening,,
71,567,1,4,,855531,2406,Inactive,55956923.0,3350.0,,,Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists,Screening,,
72,568,1,7,,855531,2406,Inactive,5729877.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
73,568,1,7,,855531,2406,Inactive,24234686.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
74,570,1,4,,855531,2406,Inactive,4505209.0,4322.0,,,Primary biochemical high-throughput screening assay for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
75,571,1,4,,855531,2406,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
76,572,1,5,,855531,2406,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay (Pilot Screen),Screening,,
77,573,1,4,,855531,2406,Inactive,,,,,Primary Antimicrobial Assay for E. coli BW25113 &#8710;tolC::kan Protocol for 384-well HTS,Screening,,
78,574,1,3,,855531,2406,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
79,575,1,4,,855531,2406,Active,,,,,Human Endothelial Cell Proliferation Assay,Screening,,
80,576,1,2,,855531,2406,Inactive,67191027.0,3676.0,,,Auto-fluorescence of compounds effecting screening of VLA-4 Integrin,Other,,
81,577,1,1,,855531,2406,Inactive,11528014.0,912267.0,,,HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase,Screening,,
82,580,1,5,,855531,2406,Inconclusive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay,Screening,,
83,581,2,2,,855531,2406,Inactive,15680217.0,1511.0,,,Cathepsin G,Screening,,
84,583,2,6,,855531,2406,Inactive,123271505.0,,,IC50,High Throughput Screening Assay for Hsp70 Inhibitors,Confirmatory,,
85,584,1,3,,17389712,2406,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
86,585,1,4,,17389712,2406,Inconclusive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
87,587,1,5,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
88,588,1,4,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
89,589,1,3,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
90,590,1,3,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
91,591,1,4,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
92,592,1,6,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
93,593,1,4,,855531,2406,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
94,594,1,4,,855531,2406,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
95,595,1,3,,17389712,2406,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
96,596,1,2,,17389712,2406,Inconclusive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
97,597,1,3,,855531,2406,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
98,598,1,4,,855531,2406,Active,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen,Screening,,
99,601,1,4,,855531,2406,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance Pilot Screen,Screening,,
100,602,1,4,,855531,2406,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance,Screening,,
101,603,1,2,,17389712,2406,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
102,604,1,3,,855531,2406,Inactive,41872583.0,9475.0,,,Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2),Screening,,
103,605,1,2,,17389712,2406,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
104,606,1,3,,855531,2406,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
105,606,1,3,,855531,2406,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
106,609,1,2,,855531,2406,Inactive,,,,,Chemical Complementation Assay for MKP-3,Screening,,
107,614,1,6,,855531,2406,Inactive,116734717.0,249.0,,,HTS colorimetric detection of phosphate released in TNAP reaction,Screening,,
108,615,1,6,,855531,2406,Inactive,116734717.0,249.0,,,HTS colorimetric detection of p-nitrophenol released in TNAP reaction,Screening,,
109,618,2,6,,855531,2406,Inactive,6690534.0,4323.0,,EC50,Luminescent HTS for small molecule inhibitors of MT1-MMP transcription,Confirmatory,,
110,620,2,5,,855531,2406,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells),Confirmatory,,
111,622,1,2,,855531,2406,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Negative Modulator Primary Screen,Screening,,
112,623,1,3,,855531,2406,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Positive Modulator: Primary Screen,Screening,,
113,624,1,2,,855531,2406,Inactive,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Primary Screen,Screening,,
114,625,1,2,,855531,2406,Inactive,,,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Primary Screen,Screening,,
115,626,1,3,,855531,2406,Inactive,,,,,Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist  Primary Screen,Screening,,
116,628,2,4,,855531,2406,Inactive,113121.0,25229.0,,,Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen,Screening,,
117,629,1,3,,855531,2406,Active,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors,Screening,,
118,630,1,1,,855531,2406,Inactive,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
119,631,1,4,,855531,2406,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
120,631,1,4,,855531,2406,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
121,633,1,3,,855531,2406,Active,10835013.0,2100.0,,,HTS for Estrogen Receptor-beta Coactivator Binding inhibitors,Screening,,
122,636,1,4,,855531,2406,Inactive,,,,,Modulators of Post-Golgi Transport - 384-well pilot screen,Screening,,
123,637,1,4,,855531,2406,Active,,,,,Modulators of Post-Golgi Transport - 1536-well pilot screen,Screening,,
124,639,1,2,,855531,2406,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators,Screening,,
125,641,1,4,,855531,2406,Inactive,,,,,Allosteric Modulators of D1 Receptors: Primary Screen,Screening,,
126,645,1,4,,855531,2406,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression - 66K library screen,Screening,,
127,648,1,3,,855531,2406,Inactive,,,,,Human Endothelial Cell Proliferation Assay in 384-well format,Screening,,
128,654,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
129,655,1,1,,17389712,2406,Inconclusive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
130,656,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
131,657,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
132,658,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
133,659,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
134,660,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
135,661,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
136,662,1,1,,17389712,2406,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
137,663,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
138,664,1,1,,17389712,2406,Inconclusive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
139,665,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
140,666,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
141,667,1,1,,17389712,2406,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
142,680,1,10,,855531,2406,Inactive,180352.0,,,,Factor XIa Mixture HTS,Screening,,
143,684,1,12,,855531,2406,Inactive,317373446.0,2161.0,,,Factor XIIa Mixture HTS,Screening,,
144,686,1,1,,855531,2406,Inactive,,,,,Zebrafish Lipid Metabolism Assay---Primary Screen,Screening,,
145,687,1,17,,855531,2406,Inactive,180352.0,,,,Factor XIa Single Well HTS,Screening,,
146,701,1,17,,855531,2406,Inactive,317373446.0,2161.0,,,Factor XIIa Single Well HTS,Screening,,
147,708,1,4,,855531,2406,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Absorbance at 340 nm,Screening,,
148,709,1,2,,855531,2406,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm,Screening,,
149,713,1,2,,855531,2406,Active,118764400.0,2099.0,3.9408800000000004,IC50,Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation,Confirmatory,,
150,719,1,3,,855531,2406,Inactive,,,,,Human Lung Fibroblast Proliferation Assay,Screening,,
151,731,1,5,,855531,2406,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
152,731,1,5,,855531,2406,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
153,733,1,3,,855531,2406,Active,10835013.0,2100.0,8.14715,IC50,Estrogen Receptor-beta Coactivator Binding Inhibitors Dose Response Confirmation,Confirmatory,,
154,746,1,1,,855531,2406,Inactive,2507196.0,5602.0,,,Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3),Screening,,
155,750,1,3,,855531,2406,Inactive,,,,,Luminescent HTS for small molecule activators of MT1-MMP transcription,Screening,,
156,751,1,3,,855531,2406,Inactive,,,,,Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent),Screening,,
157,757,1,4,,855531,2406,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
158,758,1,4,,855531,2406,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
159,759,1,4,,855531,2406,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
160,760,1,4,,855531,2406,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
161,761,1,4,,855531,2406,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
162,764,1,4,,855531,2406,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
163,770,1,1,,855531,2406,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (24 Hour Treatment Protocol),Screening,,
164,771,1,2,,855531,2406,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (48 Hour Treatment Protocol),Screening,,
165,772,1,2,,855531,2406,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (72 Hour Treatment Protocol),Screening,,
166,774,1,2,,855531,2406,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Inhibition of Enzymes Frequently Used to reach a NAD/NADH Endpoint,Other,,
167,775,1,3,,855531,2406,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
168,781,1,1,,855531,2406,Active,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
169,782,1,2,,855531,2406,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
170,782,1,2,,855531,2406,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
171,793,1,2,,855531,2406,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
172,795,1,1,,855531,2406,Inactive,,,,,MLSCN Assay for Activators of Prostate Cell Differentiation,Screening,,
173,797,1,1,,855531,2406,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
174,798,2,12,,855531,2406,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
175,799,1,5,,855531,2406,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
176,800,2,11,,855531,2406,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
177,803,1,4,,855531,2406,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
178,804,1,3,,855531,2406,Active,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
179,813,1,4,,855531,2406,Inactive,116734717.0,249.0,,,HTS identification of compounds activating TNAP at intermediate concentration of phosphate acceptor detected in luminescent assay,Screening,,
180,817,1,1,,855531,2406,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
181,818,1,2,,855531,2406,Active,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
182,827,1,2,,855531,2406,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
183,828,1,5,,855531,2406,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
184,834,1,3,,855531,2406,Inactive,,,,,C. albicans biofilm killing,Screening,,
185,841,1,1,,855531,2406,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
186,847,1,2,,855531,2406,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay,Screening,,
187,849,1,2,,855531,2406,Active,,,,,"Screen for Chemicals that Shorten Yeast Lifespan, Dose response",Confirmatory,,
188,850,1,2,,855531,2406,Active,,,,,"Screen for Chemicals that Shorten Yeast Lifespan, Dose Response Permissive Growth Control",Confirmatory,,
189,861,1,1,,855531,2406,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
190,862,1,2,,855531,2406,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
191,868,1,3,,855531,2406,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
192,871,1,2,,855531,2406,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
193,873,1,13,,855531,2406,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
194,875,1,2,,17389712,2406,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
195,878,1,2,,855531,2406,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
196,880,2,1,,855531,2406,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
197,880,2,1,,855531,2406,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
198,880,2,1,,17389712,2406,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
199,880,2,1,,17389712,2406,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
200,880,2,1,,26751444,2406,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
201,880,2,1,,26751444,2406,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
202,881,2,2,,17389712,2406,Active,317373425.0,247.0,5.0119,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
203,884,1,2,,17389712,2406,Active,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
204,885,1,2,,17389712,2406,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
205,886,1,2,,17389712,2406,Active,122921310.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
206,886,1,2,,17389712,2406,Active,122921311.0,,31.6228,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
207,887,1,2,,17389712,2406,Active,1832253.0,246.0,15.8489,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
208,889,1,3,,17389712,2406,Active,1730092.0,840.0,31.6228,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
209,892,1,2,,17389712,2406,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
210,893,1,2,,17389712,2406,Active,122921310.0,,25.1189,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
211,893,1,2,,17389712,2406,Active,122921311.0,,25.1189,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
212,894,2,1,,855531,2406,Active,31542939.0,3248.0,31.6228,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
213,894,2,1,,17389712,2406,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
214,896,1,3,,17389712,2406,Inactive,15431328.0,834.0,,Potency,Confirmation Concentration-Response Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
215,897,1,2,,17389712,2406,Inactive,1730092.0,840.0,,Potency,Confirmation Concentration-Response Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
216,898,1,1,,855531,2406,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
217,900,1,3,,17389712,2406,Inconclusive,15431328.0,834.0,39.8107,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
218,902,1,2,,17389712,2406,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
219,908,1,2,,17389712,2406,Inactive,1730092.0,840.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-7: Cysteine,Confirmatory,,
220,912,1,2,,17389712,2406,Active,21392848.0,,3.1623,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
221,914,1,3,,855531,2406,Inconclusive,32879895.0,3091.0,5.0119,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
222,915,1,3,,855531,2406,Inconclusive,32879895.0,3091.0,5.0119,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
223,919,1,2,,17389712,2406,Inactive,266321.0,834.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-7: Summary,Confirmatory,,
224,920,1,2,,855531,2406,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
225,921,1,2,,17389712,2406,Active,,,39.8107,Potency,Cell Viability - LYMP2-001,Confirmatory,,
226,923,1,2,,17389712,2406,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
227,924,1,2,,17389712,2406,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
228,925,1,2,,17389712,2406,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
229,926,1,2,,17389712,2406,Unspecified,38016895.0,7253.0,31.6228,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
230,929,1,2,,17389712,2406,Inactive,266321.0,834.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-1: Cysteine,Confirmatory,,
231,932,1,4,,855531,2406,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
232,938,1,2,,17389712,2406,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
233,940,1,2,,855531,2406,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
234,946,1,2,,17389712,2406,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
235,947,1,2,,17389712,2406,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
236,948,1,2,,17389712,2406,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
237,950,1,1,,855531,2406,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
238,951,1,1,,855531,2406,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
239,952,1,1,,855531,2406,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
240,955,1,2,,17389712,2406,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
241,960,1,2,,17389712,2406,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
242,961,1,2,,17389712,2406,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
243,962,1,2,,17389712,2406,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
244,963,1,2,,17389712,2406,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
245,964,1,2,,17389712,2406,Active,,,39.8107,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
246,965,1,2,,17389712,2406,Inconclusive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
247,966,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-004,Confirmatory,,
248,967,1,2,,17389712,2406,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
249,968,1,2,,17389712,2406,Active,,,50.1187,Potency,Cell Viability - LYMP2-009,Confirmatory,,
250,969,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-011,Confirmatory,,
251,970,1,2,,17389712,2406,Active,,,50.1187,Potency,Cell Viability - LYMP2-013,Confirmatory,,
252,971,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-015,Confirmatory,,
253,972,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-017,Confirmatory,,
254,973,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-019,Confirmatory,,
255,974,1,2,,17389712,2406,Active,,,39.8107,Potency,Cell Viability - LYMP2-021,Confirmatory,,
256,975,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-023,Confirmatory,,
257,976,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-025,Confirmatory,,
258,977,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-002,Confirmatory,,
259,978,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-006,Confirmatory,,
260,979,1,2,,17389712,2406,Inconclusive,,,31.6228,Potency,Cell Viability - LYMP2-007,Confirmatory,,
261,980,1,2,,17389712,2406,Active,,,31.6228,Potency,Cell Viability - LYMP2-008,Confirmatory,,
262,981,1,2,,17389712,2406,Active,,,50.1187,Potency,Cell Viability - LYMP2-010,Confirmatory,,
263,982,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-012,Confirmatory,,
264,983,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-014,Confirmatory,,
265,984,1,2,,17389712,2406,Active,,,39.8107,Potency,Cell Viability - LYMP2-016,Confirmatory,,
266,985,1,2,,17389712,2406,Inconclusive,,,79.4328,Potency,Cell Viability - LYMP2-018,Confirmatory,,
267,986,1,2,,17389712,2406,Active,,,31.6228,Potency,Cell Viability - LYMP2-020,Confirmatory,,
268,987,1,2,,17389712,2406,Inconclusive,,,50.1187,Potency,Cell Viability - LYMP2-022,Confirmatory,,
269,988,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-024,Confirmatory,,
270,989,1,2,,17389712,2406,Inconclusive,,,39.8107,Potency,Cell Viability - LYMP2-026,Confirmatory,,
271,993,1,2,,17389712,2406,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
272,994,1,2,,17389712,2406,Active,,,50.1187,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
273,995,1,2,,17389712,2406,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
274,996,1,2,,17389712,2406,Inactive,266321.0,834.0,,Potency,Concentration-Response Counterscreen for Redox Active Inhibitors of Caspase-1: Summary,Confirmatory,,
275,1001,2,2,,855531,2406,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
276,1006,1,6,,855531,2406,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
277,1007,1,1,,855531,2406,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
278,1008,1,2,,855531,2406,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
279,1009,1,2,,855531,2406,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
280,1012,1,4,,855531,2406,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
281,1016,1,4,,855531,2406,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
282,1018,2,5,,855531,2406,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
283,1019,1,4,,855531,2406,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
284,1020,1,5,,855531,2406,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
285,1021,1,1,,855531,2406,Active,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
286,1022,1,1,,855531,2406,Active,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
287,1027,1,3,,855531,2406,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
288,1030,2,1,,855531,2406,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
289,1030,2,1,,17389712,2406,Active,30582681.0,216.0,23.7558,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
290,1032,1,2,,855531,2406,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
291,1032,1,2,,855531,2406,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
292,1040,1,2,,855531,2406,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
293,1046,1,6,,855531,2406,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
294,1048,1,1,,855531,2406,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
295,1048,1,1,,855531,2406,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
296,1049,1,1,,855531,2406,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
297,1049,1,1,,855531,2406,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
298,1051,1,1,,855531,2406,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
299,1051,1,1,,855531,2406,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
300,1060,1,1,,855531,2406,Inactive,10835013.0,2100.0,109.20100000000001,IC50,Estrogen Receptor-beta Coactivator Binding Inhibitors ELISA Secondary Assay,Confirmatory,,
301,1063,1,1,,855531,2406,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
302,1066,1,2,,855531,2406,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
303,1085,1,1,,855531,2406,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
304,1135,1,3,,855531,2406,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
305,1136,1,3,,855531,2406,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
306,1189,1,5,,48414531,2406,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
307,1194,1,3,,48414531,2406,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
308,1199,1,3,,48414531,2406,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
309,1203,1,3,,855531,2406,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
310,1205,1,4,,48414531,2406,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
311,1209,2,2,,855531,2406,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
312,1210,1,1,,855531,2406,Inactive,6166154.0,2100.0,,,Estrogen Receptor (beta) binding:  Primary Screen,Screening,,
313,1211,1,1,,855531,2406,Inactive,5821726.0,2099.0,,,Estrogen Receptor (alpha) binding: Primary Screen,Screening,,
314,1214,1,4,,855531,2406,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
315,1216,1,5,,855531,2406,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
316,1217,1,4,,855531,2406,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
317,1220,2,2,,855531,2406,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
318,1222,1,6,,855531,2406,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
319,1229,1,3,,855531,2406,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
320,1235,1,2,,855531,2406,Inactive,,,,,Alternative Pathway ELISA_orthogonal screening,Screening,,
321,1236,1,1,,855531,2406,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
322,1239,1,3,,855531,2406,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
323,1239,1,3,,855531,2406,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
324,1242,1,1,,855531,2406,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
325,1251,1,1,,855531,2406,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
326,1273,1,1,,855531,2406,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
327,1274,1,2,,855531,2406,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
328,1276,1,1,,855531,2406,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
329,1285,1,1,,855531,2406,Inactive,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
330,1296,1,1,,855531,2406,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
331,1304,1,2,,855531,2406,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
332,1321,1,2,,855531,2406,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
333,1325,1,2,,855531,2406,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
334,1326,1,4,,855531,2406,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
335,1359,1,4,,855531,2406,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
336,1362,1,2,,855531,2406,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
337,1376,1,2,,855531,2406,Active,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
338,1377,1,1,,855531,2406,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
339,1379,1,2,,855531,2406,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
340,1381,1,1,,855531,2406,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
341,1385,2,2,,855531,2406,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
342,1415,1,2,,855531,2406,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
343,1415,1,2,,855531,2406,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
344,1416,1,2,,855531,2406,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
345,1417,1,1,,855531,2406,Active,7582271.0,4170.0,1.8988900000000002,IC50,Dose Response Confirmation for Mcl-1/Noxa Interaction Inhibitors,Confirmatory,,
346,1418,1,1,,855531,2406,Active,7582271.0,4170.0,1.67,Absolute IC50,Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors,Confirmatory,,
347,1420,1,1,,855531,2406,Inactive,1628587.0,397393.0,4.75115,IC50,Dose Response Confirmation for Calpain Inhibitors,Confirmatory,,
348,1422,1,1,,855531,2406,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
349,1423,1,2,,855531,2406,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
350,1423,1,2,,855531,2406,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
351,1424,1,1,,855531,2406,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
352,1430,1,1,,855531,2406,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
353,1434,2,3,,855531,2406,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
354,1434,2,3,,855531,2406,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
355,1439,1,1,,855531,2406,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
356,1439,1,1,,855531,2406,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
357,1440,1,1,,855531,2406,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
358,1440,1,1,,855531,2406,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
359,1441,1,1,,855531,2406,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
360,1441,1,1,,855531,2406,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
361,1443,1,3,,855531,2406,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
362,1445,1,1,,855531,2406,Active,124512980.0,813945.0,42.88,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
363,1446,1,3,,855531,2406,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
364,1448,1,3,,855531,2406,Active,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
365,1452,1,1,,855531,2406,Inconclusive,154426292.0,239.0,0.7079,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
366,1452,1,1,,17389712,2406,Inconclusive,154426292.0,239.0,1.9953,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
367,1454,1,1,,855531,2406,Inconclusive,66932916.0,5594.0,39.8107,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
368,1456,1,1,,855531,2406,Active,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
369,1457,1,1,,855531,2406,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
370,1457,1,1,,17389712,2406,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
371,1458,1,1,,855531,2406,Inactive,10937869.0,6607.0,17.7828,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
372,1458,1,1,,17389712,2406,Inactive,10937869.0,6607.0,28.1838,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
373,1460,1,3,,855531,2406,Active,92096784.0,4137.0,14.1254,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
374,1461,1,2,,855531,2406,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
375,1463,1,1,,855531,2406,Inconclusive,,,10.0,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
376,1465,1,1,,855531,2406,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
377,1466,1,2,,855531,2406,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
378,1467,1,3,,855531,2406,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
379,1468,1,1,,855531,2406,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
380,1469,1,1,,855531,2406,Inconclusive,189491771.0,7068.0,50.1187,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
381,1469,1,1,,17389712,2406,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
382,1469,1,1,,26751444,2406,Inconclusive,189491771.0,7068.0,125.89299999999999,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
383,1471,2,1,,17389712,2406,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
384,1471,2,1,,26751444,2406,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
385,1476,2,1,,855531,2406,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
386,1476,2,1,,17389712,2406,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
387,1477,1,1,,855531,2406,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
388,1477,1,1,,17389712,2406,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
389,1478,2,1,,855531,2406,Inconclusive,281307097.0,,28.1838,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
390,1478,2,1,,17389712,2406,Inconclusive,281307097.0,,31.6228,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
391,1479,1,2,,855531,2406,Inconclusive,189491771.0,7068.0,50.1187,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
392,1479,1,2,,17389712,2406,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
393,1479,1,2,,26751444,2406,Inconclusive,189491771.0,7068.0,125.89299999999999,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
394,1481,1,2,,855531,2406,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
395,1486,1,3,,855531,2406,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
396,1487,1,1,,855531,2406,Inconclusive,27436948.0,4000.0,3.1623,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
397,1487,1,1,,26751444,2406,Inconclusive,27436948.0,4000.0,5.6234,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
398,1490,2,1,,855531,2406,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
399,1490,2,1,,26751444,2406,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
400,1496,1,4,,855531,2406,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
401,1496,1,4,,855531,2406,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
402,1509,1,2,,855531,2406,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
403,1510,1,3,,855531,2406,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
404,1511,1,3,,855531,2406,Active,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
405,1515,1,2,,855531,2406,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
406,1525,1,2,,855531,2406,Active,38174238.0,55283.0,,,Counterscreen assay for TRPML3 agonists: cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
407,1526,1,2,,855531,2406,Active,38174238.0,55283.0,,,Confirmation cell-based high-throughput screening assay for agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
408,1527,1,3,,855531,2406,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
409,1529,1,1,,855531,2406,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
410,1530,1,1,,855531,2406,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
411,1531,1,1,,855531,2406,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
412,1532,1,1,,855531,2406,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
413,1554,1,1,,855531,2406,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
414,1556,1,4,,855531,2406,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
415,1565,2,2,,855531,2406,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
416,1566,2,3,,855531,2406,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
417,1578,3,2,,855531,2406,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
418,1580,1,1,,8149224,2406,Active,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
419,1581,1,1,,8149224,2406,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
420,1582,1,1,,8149224,2406,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
421,1583,1,1,,8149224,2406,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
422,1584,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
423,1585,1,1,,8149224,2406,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
424,1586,1,1,,8149224,2406,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
425,1587,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
426,1588,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
427,1589,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
428,1590,1,1,,8149224,2406,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
429,1593,1,1,,8149224,2406,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
430,1594,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
431,1595,1,1,,8149224,2406,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
432,1596,1,1,,8149224,2406,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
433,1597,1,1,,8149224,2406,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
434,1598,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
435,1599,1,1,,8149224,2406,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
436,1600,1,1,,8149224,2406,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
437,1601,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
438,1602,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
439,1603,1,1,,8149224,2406,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
440,1604,1,1,,8149224,2406,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
441,1605,1,1,,8149224,2406,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
442,1606,1,1,,8149224,2406,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
443,1607,1,1,,8149224,2406,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
444,1608,1,1,,8149224,2406,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
445,1609,1,1,,8149224,2406,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
446,1610,1,1,,8149224,2406,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
447,1612,1,1,,8149224,2406,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
448,1613,1,1,,8149224,2406,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
449,1614,1,1,,8149224,2406,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
450,1616,1,1,,8149224,2406,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
451,1619,1,2,,855531,2406,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
452,1621,1,2,,855531,2406,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
453,1626,1,2,,855531,2406,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
454,1631,3,1,,855531,2406,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
455,1634,3,1,,855531,2406,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
456,1654,2,2,,855531,2406,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
457,1656,2,2,,855531,2406,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
458,1662,1,2,,855531,2406,Active,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
459,1663,1,2,,855531,2406,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
460,1672,1,3,,855531,2406,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
461,1688,1,1,,855531,2406,Active,90903231.0,3064.0,10.0,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
462,1688,1,1,,26751444,2406,Inconclusive,90903231.0,3064.0,14.1254,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
463,1700,1,2,,855531,2406,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
464,1706,1,2,,855531,2406,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
465,1721,1,2,,855531,2406,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
466,1722,1,2,,855531,2406,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
467,1766,1,1,,855531,2406,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
468,1766,1,1,,855531,2406,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
469,1766,1,1,,26751444,2406,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
470,1766,1,1,,26751444,2406,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
471,1768,1,1,,855531,2406,Inconclusive,18860839.0,4221.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
472,1768,1,1,,855531,2406,Inconclusive,56550039.0,4297.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
473,1768,1,1,,26751444,2406,Inconclusive,18860839.0,4221.0,31.6228,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
474,1768,1,1,,26751444,2406,Inconclusive,56550039.0,4297.0,31.6228,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
475,1775,1,2,,855531,2406,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
476,1776,1,2,,855531,2406,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
477,1777,3,2,,855531,2406,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
478,1778,3,3,,855531,2406,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
479,1779,2,2,,855531,2406,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
480,1789,1,2,,855531,2406,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
481,1800,1,2,,855531,2406,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
482,1813,1,2,,855531,2406,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
483,1814,1,2,,855531,2406,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
484,1817,2,2,,855531,2406,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
485,1822,1,3,,855531,2406,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
486,1825,1,1,,855531,2406,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
487,1832,2,1,,855531,2406,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
488,1835,1,2,,855531,2406,Active,487738.0,3757.0,,,Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents,Screening,,
489,1839,1,2,,855531,2406,Active,487738.0,3757.0,,,Counter screen for compounds that protect hERG from block by proarrhythmic agents,Screening,,
490,1845,1,2,,855531,2406,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
491,1850,2,1,,855531,2406,Active,,,9.37,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
492,1861,2,1,,855531,2406,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
493,1863,2,1,,855531,2406,Active,,,38.23,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
494,1865,1,1,,855531,2406,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
495,1875,2,1,,855531,2406,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
496,1885,2,1,,855531,2406,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
497,1899,1,3,,855531,2406,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
498,1903,2,3,,855531,2406,Inconclusive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
499,1906,1,3,,855531,2406,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
500,1910,1,2,,855531,2406,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
501,1942,1,1,,855531,2406,Inactive,18959272.0,170848.0,,,KCNQ2 Counter screen for compounds that protect hERG from block by proarrhythmic agents,Screening,,
502,1946,1,1,,855531,2406,Inactive,18959272.0,170848.0,,,KCNQ2 Counter screen for inhibitors that protect hERG from block by proarrhythmic agents,Screening,,
503,1947,1,2,,855531,2406,Active,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
504,1948,1,1,,17389712,2406,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
505,1950,1,3,,855531,2406,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
506,1956,1,1,,855531,2406,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
507,1961,2,2,,855531,2406,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
508,1962,1,2,,855531,2406,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
509,1974,1,2,,855531,2406,Active,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
510,1981,2,1,,855531,2406,Active,,,39.66,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhimurium using a modified counterscreen.,Confirmatory,,
511,1984,1,3,,855531,2406,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
512,1985,2,1,,855531,2406,Active,,,14.7,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen,Confirmatory,,
513,1986,1,2,,855531,2406,Active,45357394.0,,6.16,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
514,1987,1,2,,855531,2406,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
515,2006,3,2,,855531,2406,Active,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
516,2006,3,2,,855531,2406,Active,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
517,2006,3,2,,855531,2406,Active,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
518,2012,3,2,,855531,2406,Active,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
519,2013,2,2,,855531,2406,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
520,2014,3,2,,855531,2406,Active,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
521,2016,1,3,,855531,2406,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
522,2023,1,3,,855531,2406,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
523,2025,1,3,,855531,2406,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
524,2029,1,3,,855531,2406,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
525,2032,1,2,,855531,2406,Inactive,6680530.0,16518.0,,,Confirmatory screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
526,2052,2,1,,855531,2406,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
527,2057,1,2,,855531,2406,Active,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
528,2058,3,2,,855531,2406,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
529,2066,1,4,,855531,2406,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
530,2071,2,2,,855531,2406,Active,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
531,2073,2,3,,855531,2406,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
532,2073,2,3,,855531,2406,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
533,2094,1,2,,855531,2406,Inconclusive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
534,2094,1,2,,855531,2406,Inconclusive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
535,2094,1,2,,855531,2406,Inconclusive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
536,2097,1,2,,855531,2406,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
537,2098,1,1,,855531,2406,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
538,2099,1,1,,855531,2406,Inconclusive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
539,2100,1,1,,855531,2406,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
540,2101,1,1,,855531,2406,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
541,2101,1,1,,17389712,2406,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
542,2105,1,2,,855531,2406,Active,6680530.0,16518.0,,,Counter screen for compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
543,2107,1,1,,855531,2406,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
544,2107,1,1,,17389712,2406,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
545,2112,1,1,,855531,2406,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
546,2112,1,1,,17389712,2406,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
547,2120,1,1,,17389712,2406,Inconclusive,32879895.0,3091.0,39.8107,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
548,2129,1,2,,855531,2406,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
549,2130,1,3,,855531,2406,Active,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
550,2147,1,1,,855531,2406,Inconclusive,221046486.0,,39.8107,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
551,2156,2,2,,855531,2406,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
552,2174,1,3,,855531,2406,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
553,2177,1,3,,855531,2406,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
554,2205,1,1,,855531,2406,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
555,2216,1,3,,855531,2406,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
556,2221,1,2,,855531,2406,Active,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
557,2227,1,2,,855531,2406,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
558,2234,1,2,,855531,2406,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
559,2235,1,2,,855531,2406,Active,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
560,2237,1,2,,855531,2406,Active,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
561,2239,1,2,,855531,2406,Active,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
562,2242,1,1,,855531,2406,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
563,2247,1,2,,855531,2406,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
564,2252,1,1,,855531,2406,Active,,,22.4,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen,Confirmatory,,
565,2253,1,1,,855531,2406,Active,,,21.01,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhimurium identified in the primary screen,Confirmatory,,
566,2280,2,3,,855531,2406,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
567,2282,1,1,,855531,2406,Active,18959272.0,170848.0,,,Counter screen for compounds that potentiate KCNQ2 potassium channels,Screening,,
568,2283,1,1,,855531,2406,Inactive,32479527.0,3784.0,,,Specificity screen against KCNQ1 for compounds that potentiate KCNQ2 potassium channels,Screening,,
569,2287,1,1,,855531,2406,Active,18959272.0,170848.0,,,Confirmatory screen for compounds that potentiate KCNQ2 potassium channels,Screening,,
570,2288,1,1,,855531,2406,Inconclusive,,,20.7491,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
571,2289,1,1,,855531,2406,Inconclusive,,,20.7491,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
572,2300,1,3,,855531,2406,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
573,2314,1,2,,855531,2406,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
574,2314,1,2,,855531,2406,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
575,2315,1,2,,855531,2406,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
576,2315,1,2,,855531,2406,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
577,2326,1,1,,855531,2406,Inactive,194352380.0,,0.3162,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
578,2345,1,1,,855531,2406,Inactive,6680530.0,16518.0,,,Specificity screen against Kir2.1 for compounds that potentiate KCNQ2,Screening,,
579,2380,1,2,,855531,2406,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
580,2384,1,1,,855531,2406,Active,,,17.8,IC50,A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
581,2391,1,1,,855531,2406,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
582,2401,1,2,,855531,2406,Active,,,39.29,IC50,A Counter Screen to identiry small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
583,2417,1,1,,855531,2406,Inactive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
584,2435,1,2,,855531,2406,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
585,2445,1,2,,855531,2406,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
586,2451,1,2,,855531,2406,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
587,2462,1,1,,855531,2406,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
588,2462,1,1,,855531,2406,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
589,2472,1,2,,855531,2406,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
590,2517,2,1,,855531,2406,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
591,2517,2,1,,17389712,2406,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
592,2520,1,4,,855531,2406,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
593,2521,1,3,,855531,2406,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
594,2524,1,2,,855531,2406,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
595,2528,1,2,,855531,2406,Inconclusive,4557365.0,641.0,35.4813,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
596,2528,1,2,,26751444,2406,Inconclusive,4557365.0,641.0,28.1838,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
597,2540,1,2,,855531,2406,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
598,2544,1,2,,855531,2406,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
599,2546,1,1,,855531,2406,Inconclusive,188536040.0,19885.0,35.4813,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
600,2546,1,1,,17389712,2406,Active,188536040.0,19885.0,12.5893,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
601,2546,1,1,,26751444,2406,Inconclusive,188536040.0,19885.0,19.9526,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
602,2549,1,1,,855531,2406,Active,282403581.0,,39.8107,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
603,2549,1,1,,17389712,2406,Active,282403581.0,,25.1189,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
604,2550,1,3,,855531,2406,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
605,2551,1,1,,855531,2406,Inconclusive,188536040.0,19885.0,31.6228,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
606,2551,1,1,,17389712,2406,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
607,2551,1,1,,26751444,2406,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
608,2553,1,2,,855531,2406,Active,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
609,2557,1,3,,855531,2406,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
610,2558,1,1,,855531,2406,Inactive,18959272.0,170848.0,,,Mode of action - Automated patch clamp assay for KCNQ2 potentiators on Retigabine insensitive KCNQ2 Mutant W236L cell line,Screening,,
611,2563,1,1,,855531,2406,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
612,2599,1,2,,855531,2406,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
613,2606,1,2,,855531,2406,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
614,2629,1,1,,855531,2406,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
615,2642,1,2,,855531,2406,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
616,2648,1,2,,855531,2406,Active,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
617,2650,2,1,,855531,2406,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
618,2661,1,1,,855531,2406,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
619,2662,2,1,,855531,2406,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
620,2675,1,1,,855531,2406,Inactive,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
621,2676,1,2,,855531,2406,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
622,2685,1,1,,855531,2406,Inconclusive,,,16.3601,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
623,2690,1,2,,855531,2406,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
624,2716,1,1,,855531,2406,Active,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
625,2717,1,2,,855531,2406,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
626,2718,1,1,,855531,2406,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
627,2732,1,1,,855531,2406,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
628,2751,2,2,,855531,2406,Active,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
629,2796,1,4,,855531,2406,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
630,2797,1,2,,855531,2406,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
631,2805,2,2,,855531,2406,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
632,2806,2,2,,855531,2406,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
633,2825,1,2,,855531,2406,Active,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
634,26347,3,3,,103206701,2406,Unspecified,,,,,pKa value was determined,Other,12668007.0,
635,95622,3,11,,103206701,2406,Unspecified,46396283.0,3778.0,,,Maxi-K opening activity on cloned human (hSlo) large- conductance (BK) Ca(2+)-activated K+ channel expressed in Xenopus laevis oocytes at concentration of 20 uM,Other,12668007.0,
636,434955,1,2,,855531,2406,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
637,434962,1,2,,855531,2406,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
638,434973,1,3,,855531,2406,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
639,434989,1,1,,855531,2406,Active,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
640,435003,1,3,,855531,2406,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
641,435005,1,1,,855531,2406,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
642,435006,1,2,,855531,2406,Active,219518789.0,114548.0,,,Single concentration confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay,Screening,,
643,435022,2,2,,855531,2406,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
644,435030,1,2,,855531,2406,Active,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
645,435030,1,2,,855531,2406,Active,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
646,449728,1,2,,855531,2406,Active,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
647,449762,1,2,,855531,2406,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
648,449763,1,3,,855531,2406,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
649,449768,1,1,,855531,2406,Active,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
650,463075,1,1,,855531,2406,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
651,463079,1,2,,855531,2406,Active,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
652,463082,1,1,,855531,2406,Active,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
653,463104,1,2,,855531,2406,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
654,463111,1,1,,855531,2406,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
655,463115,1,1,,855531,2406,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
656,463141,1,2,,855531,2406,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
657,463165,1,1,,855531,2406,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
658,463187,1,1,,855531,2406,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
659,463189,1,1,,855531,2406,Active,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
660,463190,1,2,,855531,2406,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
661,463193,1,1,,855531,2406,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
662,463195,1,2,,855531,2406,Active,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
663,463210,1,2,,855531,2406,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
664,463212,1,1,,855531,2406,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
665,463215,1,2,,855531,2406,Active,285809906.0,856395.0,,,Single concentration confirmation of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
666,463254,1,1,,855531,2406,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
667,485270,1,1,,855531,2406,Active,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
668,485272,1,1,,855531,2406,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
669,485273,2,1,,855531,2406,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
670,485275,1,3,,855531,2406,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
671,485276,1,2,,99234233,2406,Inactive,,,,Secondary IC50,Identification of SV40 T antigen inhibitors: A Secondary Screen for the Cytotoxicity and Efficacy using BSC cells (3),Confirmatory,,
672,485281,1,1,,855531,2406,Inconclusive,254220970.0,,31.6228,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
673,485288,1,3,,99234233,2406,Active,297591903.0,29031019.0,35.7,IC50,"A confirmatory biochemical assay using the ADP-Hunter methodology, purified TAg, and ATP to quantify activity of synthesized compounds that inhibit the ATPase activity of Tag (3)",Confirmatory,,
674,485290,1,1,,855531,2406,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
675,485290,1,1,,17389712,2406,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
676,485290,1,1,,26751444,2406,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
677,485294,1,1,,855531,2406,Inconclusive,119389684.0,,25.1189,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
678,485297,1,1,,855531,2406,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
679,485298,1,1,,855531,2406,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
680,485313,1,2,,855531,2406,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
681,485314,1,1,,855531,2406,Active,4505931.0,5423.0,22.3872,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
682,485317,1,2,,855531,2406,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
683,485341,1,1,,855531,2406,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
684,485344,1,1,,855531,2406,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
685,485346,1,1,,855531,2406,Active,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
686,485346,1,1,,855531,2406,Active,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
687,485347,1,2,,855531,2406,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
688,485349,1,1,,855531,2406,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
689,485353,2,1,,855531,2406,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
690,485358,1,1,,855531,2406,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
691,485360,1,1,,855531,2406,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
692,485364,1,1,,855531,2406,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
693,485367,1,2,,855531,2406,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
694,488837,1,1,,855531,2406,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
695,488847,1,3,,855531,2406,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
696,488890,1,2,,855531,2406,Inconclusive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
697,488922,1,2,,855531,2406,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
698,488942,1,1,,855531,2406,Inactive,15645703.0,899625.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex,Screening,,
699,488942,1,1,,855531,2406,Inactive,15646160.0,899738.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex,Screening,,
700,488955,1,1,,855531,2406,Active,16130723.0,947287.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
701,488955,1,1,,855531,2406,Active,16130724.0,947286.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
702,488955,1,1,,855531,2406,Active,16130726.0,947294.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
703,488956,1,1,,855531,2406,Inactive,,,,,Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability,Screening,,
704,488975,1,2,,855531,2406,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
705,488977,1,2,,855531,2406,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
706,489028,1,2,,855531,2406,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
707,489028,1,2,,855531,2406,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
708,489030,2,1,,855531,2406,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
709,489031,2,1,,855531,2406,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
710,492947,1,1,,855531,2406,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
711,492967,1,2,,99301727,2406,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
712,493011,1,1,,855531,2406,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
713,493012,1,1,,855531,2406,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
714,493014,1,1,,855531,2406,Inconclusive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
715,493036,1,2,,855531,2406,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
716,493056,1,1,,855531,2406,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
717,493084,1,1,,855531,2406,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
718,493162,1,2,,99301727,2406,Active,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
719,500917,3,3,,103206701,2406,Active,,,,,Inhibition of heat-induced AML1-ETO protein expression in heterozygous transgenic zebrafish embryo by Western blot analysis,Other,19172146.0,
720,504327,1,1,,855531,2406,Inconclusive,153791535.0,2648.0,25.1189,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
721,504332,1,1,,855531,2406,Inconclusive,168985070.0,,79.4328,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
722,504333,1,1,,855531,2406,Active,6683500.0,29994.0,50.1187,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
723,504406,1,1,,855531,2406,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
724,504408,2,1,,855531,2406,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
725,504466,1,1,,855531,2406,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
726,504467,1,1,,855531,2406,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
727,504607,1,1,,855531,2406,Inactive,,,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay,Screening,,
728,504651,1,1,,855531,2406,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
729,504652,1,1,,855531,2406,Active,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
730,504660,1,1,,855531,2406,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
731,504668,1,1,,855531,2406,Inactive,728984.0,672.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
732,504668,1,1,,855531,2406,Inactive,116241265.0,580.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
733,504706,1,1,,855531,2406,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
734,504749,1,3,,26751444,2406,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
735,504749,1,3,,104171365,2406,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
736,504749,1,3,1.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
737,504749,1,3,2.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
738,504749,1,3,3.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
739,504749,1,3,4.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
740,504749,1,3,5.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
741,504749,1,3,6.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
742,504749,1,3,7.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
743,504749,1,3,8.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
744,504749,1,3,9.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
745,504749,1,3,10.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
746,504749,1,3,11.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
747,504749,1,3,12.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
748,504749,1,3,13.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
749,504749,1,3,14.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
750,504749,1,3,15.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
751,504749,1,3,16.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
752,504749,1,3,17.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
753,504749,1,3,18.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
754,504749,1,3,19.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
755,504749,1,3,20.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
756,504749,1,3,21.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
757,504749,1,3,22.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
758,504749,1,3,23.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
759,504749,1,3,24.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
760,504749,1,3,25.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
761,504749,1,3,26.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
762,504749,1,3,27.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
763,504749,1,3,28.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
764,504749,1,3,29.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
765,504749,1,3,30.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
766,504749,1,3,31.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
767,504749,1,3,32.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
768,504749,1,3,33.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
769,504749,1,3,34.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
770,504749,1,3,35.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
771,504749,1,3,36.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
772,504749,1,3,37.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
773,504749,1,3,38.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
774,504749,1,3,39.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
775,504749,1,3,40.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
776,504749,1,3,41.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
777,504749,1,3,42.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
778,504749,1,3,43.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
779,504749,1,3,44.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
780,504749,1,3,45.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
781,504749,1,3,46.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
782,504749,1,3,47.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
783,504749,1,3,48.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
784,504749,1,3,49.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
785,504749,1,3,50.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
786,504749,1,3,51.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
787,504749,1,3,52.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
788,504749,1,3,53.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
789,504749,1,3,54.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
790,504749,1,3,55.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
791,504749,1,3,56.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
792,504749,1,3,57.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
793,504749,1,3,58.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
794,504749,1,3,59.0,104171365,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
795,504749,1,3,60.0,104171365,2406,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
796,504749,1,3,61.0,26751444,2406,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
797,504810,1,2,,855531,2406,Active,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
798,504812,1,2,,855531,2406,Active,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
799,504832,1,1,,855531,2406,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
800,504832,1,1,,104171365,2406,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
801,504834,1,1,,855531,2406,Inconclusive,,,18.526,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
802,504834,1,1,,104171365,2406,Inconclusive,,,15.1014,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
803,504842,1,1,,855531,2406,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
804,504847,1,1,,104171365,2406,Active,63054845.0,7421.0,28.1838,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
805,504865,1,1,,104171365,2406,Active,118600387.0,7398.0,35.4813,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
806,540256,1,2,,855531,2406,Inconclusive,,,29.0929,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
807,540275,1,1,,855531,2406,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
808,540276,1,2,,855531,2406,Inconclusive,420597.0,,29.0929,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
809,540276,1,2,,17389712,2406,Inconclusive,420597.0,,29.0929,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
810,540276,1,2,,26751444,2406,Inconclusive,420597.0,,29.0929,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
811,540276,1,2,,50100878,2406,Inconclusive,420597.0,,29.0929,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
812,540276,1,2,,104171365,2406,Inconclusive,420597.0,,29.0929,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
813,540277,1,1,,855531,2406,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
814,588209,2,3,,103206701,2406,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
815,588210,2,4,,103206701,2406,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
816,588342,1,1,,855531,2406,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
817,588511,1,2,,855531,2406,Active,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
818,588513,1,1,,17389712,2406,Active,348019627.0,2099.0,39.8107,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
819,588513,1,1,,26751444,2406,Inconclusive,348019627.0,2099.0,22.3872,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
820,588514,1,1,,17389712,2406,Inconclusive,348019627.0,2099.0,28.1838,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
821,588514,1,1,,26751444,2406,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
822,588515,1,1,,17389712,2406,Inconclusive,124375976.0,367.0,8.9125,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
823,588515,1,1,,26751444,2406,Inconclusive,124375976.0,367.0,6.3096,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
824,588516,1,1,,17389712,2406,Inconclusive,124375976.0,367.0,11.2202,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
825,588516,1,1,,26751444,2406,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
826,588526,1,1,,17389712,2406,Inconclusive,325495553.0,9971.0,50.1187,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
827,588526,1,1,,26751444,2406,Inconclusive,325495553.0,9971.0,14.1254,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
828,588527,1,1,,17389712,2406,Inconclusive,325495553.0,9971.0,31.6228,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
829,588527,1,1,,26751444,2406,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
830,588532,1,1,,17389712,2406,Inconclusive,311348376.0,2908.0,0.2512,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
831,588532,1,1,,26751444,2406,Inconclusive,311348376.0,2908.0,2.5119,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
832,588533,1,1,,17389712,2406,Inconclusive,311348376.0,2908.0,6.3096,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
833,588533,1,1,,26751444,2406,Inconclusive,311348376.0,2908.0,2.2387,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
834,588534,1,1,,17389712,2406,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
835,588534,1,1,,26751444,2406,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
836,588535,1,1,,17389712,2406,Inconclusive,216409690.0,5467.0,39.8107,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
837,588535,1,1,,26751444,2406,Inconclusive,216409690.0,5467.0,44.6684,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
838,588536,1,1,,17389712,2406,Inconclusive,216409692.0,5468.0,50.1187,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
839,588536,1,1,,26751444,2406,Inconclusive,216409692.0,5468.0,44.6684,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
840,588537,1,1,,17389712,2406,Inconclusive,216409692.0,5468.0,3.5481,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
841,588537,1,1,,26751444,2406,Inconclusive,216409692.0,5468.0,2.8184,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
842,588541,1,1,,17389712,2406,Inconclusive,216409708.0,7421.0,12.5893,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
843,588541,1,1,,26751444,2406,Inconclusive,216409708.0,7421.0,28.1838,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
844,588543,1,1,,17389712,2406,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
845,588543,1,1,,26751444,2406,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
846,588544,1,1,,17389712,2406,Inconclusive,325495497.0,6256.0,15.8489,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
847,588544,1,1,,26751444,2406,Inconclusive,325495497.0,6256.0,3.1623,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
848,588545,1,1,,17389712,2406,Inconclusive,189491771.0,7068.0,50.1187,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
849,588545,1,1,,26751444,2406,Inconclusive,189491771.0,7068.0,39.8107,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
850,588546,1,1,,17389712,2406,Inconclusive,325495497.0,6256.0,35.4813,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
851,588546,1,1,,26751444,2406,Active,325495497.0,6256.0,25.1189,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
852,588547,1,1,,17389712,2406,Inconclusive,189491771.0,7068.0,44.6684,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
853,588547,1,1,,26751444,2406,Inconclusive,189491771.0,7068.0,10.0,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
854,588579,1,1,,104171365,2406,Inconclusive,7705344.0,51426.0,33.5875,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
855,588627,1,1,,855531,2406,Active,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
856,588675,1,1,,855531,2406,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
857,588676,1,1,,855531,2406,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
858,588812,1,1,,17389712,2406,Unspecified,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
859,588812,1,1,1.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
860,588812,1,1,2.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
861,588812,1,1,3.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
862,588812,1,1,4.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
863,588812,1,1,5.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
864,588812,1,1,6.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
865,588812,1,1,7.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
866,588812,1,1,8.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
867,588812,1,1,9.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
868,588812,1,1,10.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
869,588812,1,1,11.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
870,588812,1,1,12.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
871,588812,1,1,13.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
872,588812,1,1,14.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
873,588812,1,1,15.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
874,588812,1,1,16.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
875,588812,1,1,17.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
876,588812,1,1,18.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
877,588812,1,1,19.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
878,588812,1,1,20.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
879,588812,1,1,21.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
880,588812,1,1,22.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
881,588812,1,1,23.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
882,588812,1,1,24.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
883,588812,1,1,25.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
884,588812,1,1,26.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
885,588812,1,1,27.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
886,588812,1,1,28.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
887,588812,1,1,29.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
888,588812,1,1,30.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
889,588812,1,1,31.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
890,588812,1,1,32.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
891,588812,1,1,33.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
892,588812,1,1,34.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
893,588812,1,1,35.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
894,588812,1,1,36.0,17389712,2406,Inactive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
895,588812,1,1,37.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
896,588812,1,1,38.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
897,588812,1,1,39.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
898,588812,1,1,40.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
899,588812,1,1,41.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
900,588812,1,1,42.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
901,588812,1,1,43.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
902,588812,1,1,44.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
903,588812,1,1,45.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
904,588812,1,1,46.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
905,588812,1,1,47.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
906,588812,1,1,48.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
907,588812,1,1,49.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
908,588812,1,1,50.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
909,588812,1,1,51.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
910,588812,1,1,52.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
911,588812,1,1,53.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
912,588812,1,1,54.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
913,588812,1,1,55.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
914,588812,1,1,56.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
915,588812,1,1,57.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
916,588812,1,1,58.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
917,588812,1,1,59.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
918,588812,1,1,60.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
919,588812,1,1,61.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
920,588812,1,1,62.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
921,588812,1,1,63.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
922,588812,1,1,64.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
923,588812,1,1,65.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
924,588812,1,1,66.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
925,588812,1,1,67.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
926,588812,1,1,68.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
927,588812,1,1,69.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
928,588812,1,1,70.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
929,588812,1,1,71.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
930,588812,1,1,72.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
931,588812,1,1,73.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
932,588812,1,1,74.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
933,588812,1,1,75.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
934,588812,1,1,76.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
935,588812,1,1,77.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
936,588812,1,1,78.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
937,588812,1,1,79.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
938,588812,1,1,80.0,17389712,2406,Active,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
939,588812,1,1,81.0,17389712,2406,Inconclusive,,,,,Cell Viability Profiling of Human Lymphoblast Cell Lines,Other,,
940,588813,1,1,,17389712,2406,Unspecified,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
941,588813,1,1,1.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
942,588813,1,1,2.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
943,588813,1,1,3.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
944,588813,1,1,4.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
945,588813,1,1,5.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
946,588813,1,1,6.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
947,588813,1,1,7.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
948,588813,1,1,8.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
949,588813,1,1,9.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
950,588813,1,1,10.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
951,588813,1,1,11.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
952,588813,1,1,12.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
953,588813,1,1,13.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
954,588813,1,1,14.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
955,588813,1,1,15.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
956,588813,1,1,16.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
957,588813,1,1,17.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
958,588813,1,1,18.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
959,588813,1,1,19.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
960,588813,1,1,20.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
961,588813,1,1,21.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
962,588813,1,1,22.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
963,588813,1,1,23.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
964,588813,1,1,24.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
965,588813,1,1,25.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
966,588813,1,1,26.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
967,588813,1,1,27.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
968,588813,1,1,28.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
969,588813,1,1,29.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
970,588813,1,1,30.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
971,588813,1,1,31.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
972,588813,1,1,32.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
973,588813,1,1,33.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
974,588813,1,1,34.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
975,588813,1,1,35.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
976,588813,1,1,36.0,17389712,2406,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
977,588813,1,1,37.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
978,588813,1,1,38.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
979,588813,1,1,39.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
980,588813,1,1,40.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
981,588813,1,1,41.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
982,588813,1,1,42.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
983,588813,1,1,43.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
984,588813,1,1,44.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
985,588813,1,1,45.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
986,588813,1,1,46.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
987,588813,1,1,47.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
988,588813,1,1,48.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
989,588813,1,1,49.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
990,588813,1,1,50.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
991,588813,1,1,51.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
992,588813,1,1,52.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
993,588813,1,1,53.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
994,588813,1,1,54.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
995,588813,1,1,55.0,17389712,2406,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
996,588813,1,1,56.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
997,588813,1,1,57.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
998,588813,1,1,58.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
999,588813,1,1,59.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1000,588813,1,1,60.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1001,588813,1,1,61.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1002,588813,1,1,62.0,17389712,2406,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1003,588813,1,1,63.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1004,588813,1,1,64.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1005,588813,1,1,65.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1006,588813,1,1,66.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1007,588813,1,1,67.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1008,588813,1,1,68.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1009,588813,1,1,69.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1010,588813,1,1,70.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1011,588813,1,1,71.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1012,588813,1,1,72.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1013,588813,1,1,73.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1014,588813,1,1,74.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1015,588813,1,1,75.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1016,588813,1,1,76.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1017,588813,1,1,77.0,17389712,2406,Inactive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1018,588813,1,1,78.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1019,588813,1,1,79.0,17389712,2406,Inconclusive,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1020,588813,1,1,80.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1021,588813,1,1,81.0,17389712,2406,Active,,,,,Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines,Other,,
1022,588834,2,1,,17389712,2406,Inactive,325651834.0,3757.0,79.4328,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1023,588834,2,1,,26751444,2406,Inactive,325651834.0,3757.0,35.4813,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1024,602276,1,1,,855531,2406,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-SeV Stimulus,Screening,,
1025,602277,1,1,,855531,2406,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus,Screening,,
1026,602332,1,1,,104171365,2406,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1027,624030,1,2,,104171365,2406,Inconclusive,160794.0,,36.1254,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
1028,624031,1,2,,104171365,2406,Inconclusive,,,36.1254,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
1029,624032,1,2,,104171365,2406,Active,8393992.0,24660.0,18.1056,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
1030,624044,1,2,,104171365,2406,Inconclusive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
1031,624170,1,1,,104171365,2406,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1032,624172,1,1,,104171365,2406,Inactive,1724069.0,2740.0,14.1254,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1033,624173,1,3,,104171365,2406,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1034,624296,1,1,,855531,2406,Inconclusive,7705682.0,51053.0,0.8199,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1035,624296,1,1,,26751444,2406,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1036,624296,1,1,,104171365,2406,Inconclusive,7705682.0,51053.0,1.8837,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1037,624297,1,1,,855531,2406,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1038,624297,1,1,,26751444,2406,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1039,624297,1,1,,104171365,2406,Inconclusive,7705682.0,51053.0,35.4813,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1040,625144,5,5,,103206701,2406,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
1041,625145,4,7,,103206701,2406,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
1042,625146,5,5,,103206701,2406,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
1043,625147,4,7,,103206701,2406,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
1044,625148,4,7,,103206701,2406,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
1045,625149,4,7,,103206701,2406,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
1046,625150,5,5,,103206701,2406,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
1047,625151,4,7,,103206701,2406,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1048,625152,4,7,,103206701,2406,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1049,625153,4,7,,103206701,2406,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1050,625154,4,7,,103206701,2406,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1051,625155,4,7,,103206701,2406,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
1052,625156,1,9,,103206701,2406,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
1053,625157,6,2,,103206701,2406,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
1054,625158,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
1055,625159,5,5,,103206701,2406,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
1056,625160,1,9,,103206701,2406,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
1057,625161,4,7,,103206701,2406,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
1058,625162,4,7,,103206701,2406,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
1059,625163,4,7,,103206701,2406,Active,2851402.0,4988.0,5.507000000000001,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
1060,625164,1,6,,103206701,2406,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
1061,625165,3,4,,103206701,2406,Active,,,2.7230000000000003,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
1062,625166,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
1063,625167,5,5,,103206701,2406,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
1064,625168,4,7,,103206701,2406,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
1065,625169,1,6,,103206701,2406,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
1066,625170,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
1067,625171,4,7,,103206701,2406,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
1068,625172,4,7,,103206701,2406,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
1069,625173,5,5,,103206701,2406,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
1070,625174,5,5,,103206701,2406,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
1071,625175,5,5,,103206701,2406,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
1072,625176,1,9,,103206701,2406,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
1073,625177,5,5,,103206701,2406,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
1074,625178,5,5,,103206701,2406,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
1075,625179,1,9,,103206701,2406,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
1076,625180,5,5,,103206701,2406,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
1077,625181,5,5,,103206701,2406,Active,119554.0,5594.0,0.385,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
1078,625182,5,5,,103206701,2406,Active,2499600.0,1432.0,0.318,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
1079,625183,5,5,,103206701,2406,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
1080,625184,5,5,,103206701,2406,Active,2811086.0,1956.0,0.614,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1081,625185,5,5,,103206701,2406,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1082,625186,5,5,,103206701,2406,Active,119533.0,2064.0,2.147,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1083,625187,5,5,,103206701,2406,Active,125474.0,3932.0,2.255,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
1084,625188,1,9,,103206701,2406,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
1085,625189,1,7,,103206701,2406,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
1086,625190,4,5,,103206701,2406,Active,,,5.515,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
1087,625191,4,7,,103206701,2406,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
1088,625192,4,7,,103206701,2406,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
1089,625193,5,5,,103206701,2406,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
1090,625194,4,7,,103206701,2406,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
1091,625195,4,7,,103206701,2406,Active,543740.0,135.0,1.167,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
1092,625196,5,6,,103206701,2406,Active,803374855.0,140.0,0.8290000000000001,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
1093,625197,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
1094,625198,4,7,,103206701,2406,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
1095,625199,4,7,,103206701,2406,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
1096,625200,4,7,,103206701,2406,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
1097,625201,4,7,,103206701,2406,Active,1351829.0,150.0,3.824,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
1098,625202,4,7,,103206701,2406,Active,613504690.0,151.0,1.226,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
1099,625203,4,7,,103206701,2406,Active,20141211.0,152.0,4.3919999999999995,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
1100,625204,4,7,,103206701,2406,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
1101,625205,4,7,,103206701,2406,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
1102,625206,4,7,,103206701,2406,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
1103,625207,4,7,,103206701,2406,Active,128616.0,6530.0,1.235,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
1104,625208,5,5,,103206701,2406,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
1105,625209,4,7,,103206701,2406,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
1106,625210,3,4,,103206701,2406,Active,,,5.022,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
1107,625211,1,6,,103206701,2406,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
1108,625212,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
1109,625213,4,7,,103206701,2406,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
1110,625214,1,9,,103206701,2406,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
1111,625215,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
1112,625216,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
1113,625217,4,7,,103206701,2406,Active,1168220.0,3357.0,6.789,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
1114,625218,4,7,,103206701,2406,Active,112816.0,3358.0,8.78,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
1115,625219,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
1116,625220,4,7,,103206701,2406,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
1117,625221,4,7,,103206701,2406,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
1118,625222,4,7,,103206701,2406,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
1119,625223,4,7,,103206701,2406,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
1120,625224,3,4,,103206701,2406,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
1121,625225,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
1122,625226,4,7,,103206701,2406,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
1123,625227,4,7,,103206701,2406,Active,229462950.0,6865.0,4.659,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
1124,625228,4,7,,103206701,2406,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
1125,625229,5,5,,103206701,2406,Active,254763392.0,6916.0,1.84,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
1126,625230,1,6,,103206701,2406,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
1127,625231,4,7,,103206701,2406,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
1128,625232,1,9,,103206701,2406,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
1129,625233,4,7,,103206701,2406,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
1130,625234,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
1131,625235,4,7,,103206701,2406,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
1132,625236,5,5,,103206701,2406,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
1133,625237,4,7,,103206701,2406,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
1134,625238,4,7,,103206701,2406,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
1135,625239,4,7,,103206701,2406,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
1136,625240,1,9,,103206701,2406,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
1137,625241,4,7,,103206701,2406,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
1138,625242,4,7,,103206701,2406,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
1139,625243,5,5,,103206701,2406,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
1140,625244,5,5,,103206701,2406,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
1141,625245,5,5,,103206701,2406,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1142,625246,1,9,,103206701,2406,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
1143,625247,5,5,,103206701,2406,Unspecified,60416369.0,1557.0,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1144,625248,5,5,,103206701,2406,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1145,625249,5,5,,103206701,2406,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1146,625250,5,5,,103206701,2406,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
1147,625251,5,5,,103206701,2406,Unspecified,116241312.0,1576.0,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
1148,625252,4,7,,103206701,2406,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
1149,625253,4,7,,103206701,2406,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
1150,625254,4,7,,103206701,2406,Active,1169206.0,1814.0,4.218,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
1151,625255,4,7,,103206701,2406,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
1152,625256,4,7,,103206701,2406,Active,266667.0,6531.0,2.181,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
1153,625257,4,7,,103206701,2406,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
1154,625258,4,7,,103206701,2406,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
1155,625259,4,7,,103206701,2406,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
1156,625260,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
1157,625261,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
1158,625262,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
1159,625263,4,7,,103206701,2406,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
1160,625264,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
1161,625265,1,6,,103206701,2406,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
1162,625266,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
1163,625267,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
1164,625268,4,2,,103206701,2406,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
1165,625268,4,2,,103206701,2406,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
1166,625268,4,2,,103206701,2406,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
1167,625268,4,2,,103206701,2406,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
1168,625269,4,7,,103206701,2406,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
1169,625270,4,7,,103206701,2406,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
1170,625271,5,5,,103206701,2406,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
1171,625272,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
1172,625273,4,6,,103206701,2406,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
1173,625274,1,6,,103206701,2406,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
1174,625275,3,4,,103206701,2406,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
1175,625295,1,3,,103206701,2406,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data,Other,22194678.0,
1176,651631,4,1,,144204383,2406,Active,269849759.0,7157.0,11.8832,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1177,651631,4,1,,144207582,2406,Inconclusive,269849759.0,7157.0,8.6525,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1178,651631,4,1,,144213236,2406,Active,269849759.0,7157.0,21.6899,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1179,651632,4,1,,144204383,2406,Inactive,296439460.0,79915.0,10.5909,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1180,651632,4,1,,144207582,2406,Inactive,296439460.0,79915.0,0.7712,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1181,651632,4,1,,144213236,2406,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1182,651633,4,1,,144204383,2406,Active,,,2.6603,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1183,651633,4,1,,144207582,2406,Active,,,9.7083,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1184,651633,4,1,,144213236,2406,Active,,,17.2289,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1185,651634,4,1,,144204383,2406,Active,,,11.8832,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1186,651634,4,1,,144207582,2406,Active,,,30.7002,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1187,651634,4,1,,144213236,2406,Active,,,48.5577,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1188,651741,1,1,,17389712,2406,Inconclusive,20149576.0,4780.0,7.4978,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1189,651741,1,1,,144204383,2406,Inconclusive,20149576.0,4780.0,76.9588,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1190,651743,1,1,,17389712,2406,Active,269849759.0,7157.0,7.9433,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1191,651743,1,1,,26751444,2406,Active,269849759.0,7157.0,14.1254,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1192,651749,1,1,,17389712,2406,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1193,651749,1,1,,26751444,2406,Inconclusive,34577122.0,4790.0,50.1187,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1194,651751,1,1,,17389712,2406,Inactive,5702233.0,84385.0,70.7946,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1195,651751,1,1,,26751444,2406,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1196,651754,1,1,,17389712,2406,Active,,,10.5909,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
1197,651755,1,1,,17389712,2406,Active,,,13.3332,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
1198,651757,1,1,,17389712,2406,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
1199,651758,1,1,,17389712,2406,Inconclusive,186368.0,3576.0,74.97800000000001,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
1200,651777,1,1,,17389712,2406,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1201,651777,1,1,,26751444,2406,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1202,651778,1,1,,17389712,2406,Active,3041727.0,5465.0,28.1838,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1203,651778,1,1,,26751444,2406,Active,3041727.0,5465.0,25.1189,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1204,651802,1,1,,17389712,2406,Active,49066040.0,6097.0,4.7308,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1205,651820,1,1,,855531,2406,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1206,651838,1,1,,17389712,2406,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1207,651838,1,1,,26751444,2406,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1208,651838,1,1,1.0,17389712,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1209,651838,1,1,1.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1210,651838,1,1,2.0,17389712,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1211,651838,1,1,2.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1212,651838,1,1,3.0,17389712,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1213,651838,1,1,3.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1214,651838,1,1,4.0,17389712,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1215,651838,1,1,4.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1216,651838,1,1,5.0,17389712,2406,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1217,651838,1,1,5.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1218,651838,1,1,6.0,17389712,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1219,651838,1,1,6.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1220,651838,1,1,7.0,17389712,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1221,651838,1,1,7.0,26751444,2406,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1222,651838,1,1,8.0,17389712,2406,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1223,651838,1,1,8.0,26751444,2406,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1224,652048,1,2,,144204383,2406,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1225,652051,1,1,,144204383,2406,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1226,686978,1,1,,144204383,2406,Active,79154014.0,55775.0,14.9631,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1227,686979,1,1,,144204383,2406,Inconclusive,79154014.0,55775.0,33.4983,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1228,720516,2,1,,144204383,2406,Inconclusive,296439460.0,79915.0,8.41267,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1229,720516,2,1,,144207582,2406,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1230,720516,2,1,,144213236,2406,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1231,720532,1,1,,144204383,2406,Inconclusive,420597.0,,31.6228,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1232,720533,1,1,,144204383,2406,Inconclusive,,,14.1254,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1233,720552,2,1,,144204383,2406,Active,269849759.0,7157.0,17.2756,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1234,720552,2,1,,144207582,2406,Inconclusive,269849759.0,7157.0,62.6817,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1235,720552,2,1,,144213236,2406,Inconclusive,269849759.0,7157.0,34.3762,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1236,720634,2,1,,144204383,2406,Inconclusive,,,10.5909,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1237,720634,2,1,,144207582,2406,Active,,,13.7133,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1238,720634,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1239,720635,2,1,,144204383,2406,Active,,,1.0591,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1240,720635,2,1,,144207582,2406,Active,,,0.0687,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1241,720635,2,1,,144213236,2406,Active,,,0.8635,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1242,720636,1,1,,17389712,2406,Inactive,20149576.0,4780.0,66.8242,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1243,720636,1,1,,144204383,2406,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1244,720637,2,1,,144204383,2406,Active,,,1.33332,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1245,720637,2,1,,144207582,2406,Active,,,0.37194099999999997,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1246,720637,2,1,,144213236,2406,Active,,,1.00676,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1247,720652,1,1,,17389712,2406,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1248,720653,1,1,,17389712,2406,Inconclusive,,,25.1189,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1249,720653,1,1,,26751444,2406,Inconclusive,,,25.1189,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1250,720659,1,1,,17389712,2406,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1251,720659,1,1,,26751444,2406,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1252,720674,2,2,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1253,720674,2,2,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1254,720674,2,2,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1255,720675,2,2,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1256,720675,2,2,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1257,720675,2,2,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1258,720678,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1259,720678,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1260,720678,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1261,720679,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1262,720679,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1263,720679,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1264,720680,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1265,720680,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1266,720680,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1267,720681,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1268,720681,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1269,720681,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1270,720682,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1271,720682,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1272,720682,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1273,720683,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1274,720683,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1275,720683,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1276,720684,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1277,720684,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1278,720684,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1279,720685,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1280,720685,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1281,720685,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1282,720686,2,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1283,720686,2,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1284,720686,2,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1285,720687,2,2,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1286,720687,2,2,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1287,720687,2,2,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1288,720691,4,1,,144204383,2406,Inconclusive,311348376.0,2908.0,9.5205,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1289,720691,4,1,,144207582,2406,Inconclusive,311348376.0,2908.0,55.0822,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1290,720691,4,1,,144213236,2406,Inconclusive,311348376.0,2908.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1291,720692,3,1,,144204383,2406,Inconclusive,311348376.0,2908.0,1.5089,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1292,720692,3,1,,144207582,2406,Inconclusive,311348376.0,2908.0,24.6043,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1293,720692,3,1,,144213236,2406,Inconclusive,311348376.0,2908.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1294,720693,3,1,,144204383,2406,Inconclusive,,,3.7902,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1295,720693,3,1,,144207582,2406,Active,,,19.5439,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1296,720693,3,1,,144213236,2406,Active,,,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1297,720719,2,1,,144204383,2406,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1298,720719,2,1,,144207582,2406,Inconclusive,311348376.0,2908.0,49.0921,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1299,720719,2,1,,144213236,2406,Inconclusive,311348376.0,2908.0,58.1965,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1300,720725,2,1,,144204383,2406,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1301,720725,2,1,,144207582,2406,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1302,720725,2,1,,144213236,2406,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1303,721749,2,5,,103206701,2406,Active,24212063.0,6581.0,5.5,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,Confirmatory,23241029.0,
1304,721750,2,5,,103206701,2406,Active,313104181.0,6580.0,3.9,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,Confirmatory,23241029.0,
1305,721751,2,5,,103206701,2406,Active,313104182.0,6582.0,1.9,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,Confirmatory,23241029.0,
1306,721752,2,5,,103206701,2406,Active,74727585.0,146802.0,6.6,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,Confirmatory,23241029.0,
1307,721753,1,6,,103206701,2406,Unspecified,74731723.0,55244.0,,,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells at 20 uM after 1.5 mins by fluorescence assay,Other,23241029.0,
1308,721754,2,5,,103206701,2406,Active,74731723.0,55244.0,5.2,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,Confirmatory,23241029.0,
1309,743012,3,1,,144204383,2406,Active,,,11.8832,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1310,743012,3,1,,144207582,2406,Active,,,27.3616,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1311,743012,3,1,,144213236,2406,Active,,,17.2289,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1312,743014,3,1,,144204383,2406,Active,,,16.7855,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1313,743014,3,1,,144207582,2406,Active,,,17.264,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1314,743014,3,1,,144213236,2406,Active,,,15.3553,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1315,743015,3,1,,144204383,2406,Active,,,16.7855,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1316,743015,3,1,,144207582,2406,Active,,,17.264,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1317,743015,3,1,,144213236,2406,Active,,,15.3553,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1318,743033,3,1,,144204383,2406,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1319,743033,3,1,,144207582,2406,Active,,,6.1803,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1320,743033,3,1,,144213236,2406,Active,,,6.1645,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1321,743035,2,1,,144204383,2406,Inconclusive,124375976.0,367.0,21.3138,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1322,743035,2,1,,144207582,2406,Inconclusive,124375976.0,367.0,4.3753,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1323,743035,2,1,,144213236,2406,Inconclusive,124375976.0,367.0,8.7076,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1324,743036,2,1,,144204383,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1325,743036,2,1,,144207582,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1326,743036,2,1,,144213236,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1327,743040,3,1,,144204383,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1328,743040,3,1,,144207582,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1329,743040,3,1,,144213236,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1330,743041,3,1,,144204383,2406,Inconclusive,,,31.21,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1331,743041,3,1,,144207582,2406,Active,,,43.3652,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1332,743041,3,1,,144213236,2406,Active,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1333,743042,3,1,,144204383,2406,Active,124375976.0,367.0,29.8493,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1334,743042,3,1,,144207582,2406,Active,124375976.0,367.0,17.264,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1335,743042,3,1,,144213236,2406,Active,124375976.0,367.0,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1336,743053,2,1,,144204383,2406,Inconclusive,124375976.0,367.0,6.740010000000001,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1337,743053,2,1,,144207582,2406,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1338,743053,2,1,,144213236,2406,Inconclusive,124375976.0,367.0,5.18676,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1339,743054,2,1,,144204383,2406,Inconclusive,124375976.0,367.0,28.7255,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1340,743054,2,1,,144207582,2406,Inconclusive,124375976.0,367.0,18.2869,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1341,743054,2,1,,144213236,2406,Inconclusive,124375976.0,367.0,61.1306,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1342,743063,2,1,,144204383,2406,Inconclusive,124375976.0,367.0,15.6793,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1343,743063,2,1,,144207582,2406,Inconclusive,124375976.0,367.0,7.78057,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1344,743063,2,1,,144213236,2406,Inconclusive,124375976.0,367.0,6.40565,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1345,743064,3,1,,144204383,2406,Active,,,16.7855,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1346,743064,3,1,,144207582,2406,Active,,,6.1255,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1347,743064,3,1,,144213236,2406,Active,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1348,743065,3,1,,144204383,2406,Active,399498506.0,24831.0,9.4392,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1349,743065,3,1,,144207582,2406,Active,399498506.0,24831.0,4.8657,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1350,743065,3,1,,144213236,2406,Active,399498506.0,24831.0,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1351,743066,3,1,,144204383,2406,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1352,743066,3,1,,144207582,2406,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1353,743066,3,1,,144213236,2406,Inactive,399498506.0,24831.0,12.1972,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1354,743067,2,1,,144204383,2406,Inconclusive,399498506.0,24831.0,8.095939999999999,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1355,743067,2,1,,144207582,2406,Inconclusive,399498506.0,24831.0,3.07002,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1356,743067,2,1,,144213236,2406,Inconclusive,399498506.0,24831.0,6.11306,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1357,743069,2,1,,144204383,2406,Inconclusive,348019627.0,2099.0,6.74,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1358,743069,2,1,,144207582,2406,Active,348019627.0,2099.0,6.9344,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1359,743069,2,1,,144213236,2406,Inconclusive,348019627.0,2099.0,7.7606,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1360,743074,2,1,,144204383,2406,Inconclusive,,,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1361,743074,2,1,,144207582,2406,Active,,,21.9286,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1362,743074,2,1,,144213236,2406,Active,,,27.5357,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1363,743075,2,1,,144204383,2406,Inactive,348019627.0,2099.0,10.6822,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1364,743075,2,1,,144207582,2406,Inconclusive,348019627.0,2099.0,24.6043,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1365,743075,2,1,,144213236,2406,Inconclusive,348019627.0,2099.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1366,743077,2,1,,144204383,2406,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1367,743077,2,1,,144207582,2406,Inconclusive,348019627.0,2099.0,55.0889,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1368,743077,2,1,,144213236,2406,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1369,743078,2,1,,144204383,2406,Inconclusive,348019627.0,2099.0,17.5925,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1370,743078,2,1,,144207582,2406,Active,348019627.0,2099.0,7.06878,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1371,743078,2,1,,144213236,2406,Inconclusive,348019627.0,2099.0,11.8367,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1372,743079,3,1,,144204383,2406,Inconclusive,348019627.0,2099.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1373,743079,3,1,,144207582,2406,Inconclusive,348019627.0,2099.0,13.7133,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1374,743079,3,1,,144213236,2406,Inconclusive,348019627.0,2099.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1375,743080,3,1,,144204383,2406,Active,348019627.0,2099.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1376,743080,3,1,,144207582,2406,Inconclusive,348019627.0,2099.0,17.264,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1377,743080,3,1,,144213236,2406,Active,348019627.0,2099.0,48.5577,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1378,743081,3,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1379,743081,3,1,,144207582,2406,Inconclusive,,,21.7341,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1380,743081,3,1,,144213236,2406,Inconclusive,,,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1381,743083,3,1,,144204383,2406,Active,119597822.0,1588.0,21.1317,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1382,743083,3,1,,144207582,2406,Active,119597822.0,1588.0,15.3865,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1383,743083,3,1,,144213236,2406,Active,119597822.0,1588.0,15.3553,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1384,743084,3,1,,144204383,2406,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1385,743084,3,1,,144207582,2406,Inconclusive,,,19.3705,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1386,743084,3,1,,144213236,2406,Inconclusive,,,24.3365,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1387,743085,3,1,,144204383,2406,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1388,743085,3,1,,144207582,2406,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1389,743085,3,1,,144213236,2406,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1390,743086,3,1,,144204383,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1391,743086,3,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1392,743086,3,1,,144213236,2406,Inconclusive,,,43.2771,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1393,743091,2,1,,144204383,2406,Active,348019627.0,2099.0,25.6016,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1394,743091,2,1,,144207582,2406,Inconclusive,348019627.0,2099.0,17.5984,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1395,743091,2,1,,144213236,2406,Active,348019627.0,2099.0,43.2771,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1396,743094,3,1,,144204383,2406,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1397,743094,3,1,,144207582,2406,Inconclusive,216409692.0,5468.0,43.7533,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1398,743094,3,1,,144213236,2406,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1399,743120,1,1,,165230484,2406,Inactive,,,,,Confirmed inhibitors/blockers of inward-rectifying potassium ion channel Kir2.1,Other,,
1400,743122,2,1,,144204383,2406,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1401,743122,2,1,,144207582,2406,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1402,743122,2,1,,144213236,2406,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1403,743139,2,1,,144204383,2406,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1404,743139,2,1,,144207582,2406,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1405,743139,2,1,,144213236,2406,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1406,743140,2,1,,144204383,2406,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1407,743140,2,1,,144207582,2406,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1408,743140,2,1,,144213236,2406,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1409,743191,3,1,,144207582,2406,Inconclusive,216409692.0,5468.0,3.4755,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1410,743191,3,1,,144213236,2406,Inconclusive,216409692.0,5468.0,0.6917,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1411,743191,3,1,,170465515,2406,Inconclusive,216409692.0,5468.0,10.5901,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1412,743194,3,1,,144207582,2406,Active,,,1.5524,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1413,743194,3,1,,144213236,2406,Active,,,0.6917,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1414,743194,3,1,,170465515,2406,Active,,,5.3076,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1415,743199,2,1,,144207582,2406,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1416,743199,2,1,,144213236,2406,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1417,743199,2,1,,170465515,2406,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1418,743202,4,1,,144207582,2406,Inconclusive,20149576.0,4780.0,38.6492,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1419,743202,4,1,,144213236,2406,Inconclusive,20149576.0,4780.0,43.2771,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1420,743202,4,1,,170465515,2406,Inconclusive,20149576.0,4780.0,7.4972,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1421,743203,3,1,,144207582,2406,Active,,,10.8928,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1422,743203,3,1,,144213236,2406,Active,,,12.1972,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1423,743203,3,1,,170465515,2406,Active,,,3.7575,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1424,743209,3,1,,144207582,2406,Active,,,43.7533,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1425,743209,3,1,,144213236,2406,Active,,,48.9662,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1426,743209,3,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1427,743210,4,1,,144207582,2406,Inconclusive,4504517.0,3315.0,49.0921,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1428,743210,4,1,,144213236,2406,Inconclusive,4504517.0,3315.0,48.9662,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1429,743210,4,1,,170465515,2406,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1430,743211,3,1,,144207582,2406,Active,,,17.4185,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1431,743211,3,1,,144213236,2406,Active,,,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1432,743211,3,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1433,743212,3,1,,144207582,2406,Inconclusive,216409690.0,5467.0,17.4185,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1434,743212,3,1,,144213236,2406,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1435,743212,3,1,,170465515,2406,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1436,743213,3,1,,144207582,2406,Active,,,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1437,743213,3,1,,144213236,2406,Active,,,19.4938,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1438,743213,3,1,,170465515,2406,Inconclusive,,,2.9847,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1439,743215,3,1,,144207582,2406,Active,216409690.0,5467.0,21.9286,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1440,743215,3,1,,144213236,2406,Active,216409690.0,5467.0,17.3739,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1441,743215,3,1,,170465515,2406,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1442,743217,3,1,,144207582,2406,Inconclusive,325495553.0,9971.0,10.9903,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1443,743217,3,1,,144213236,2406,Inconclusive,325495553.0,9971.0,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1444,743217,3,1,,170465515,2406,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1445,743218,3,1,,144207582,2406,Active,,,15.5243,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1446,743218,3,1,,144213236,2406,Inconclusive,,,15.4845,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1447,743218,3,1,,170465515,2406,Inconclusive,,,33.4889,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1448,743219,3,1,,144207582,2406,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1449,743219,3,1,,144213236,2406,Inconclusive,20149576.0,4780.0,12.1972,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1450,743219,3,1,,170465515,2406,Inconclusive,20149576.0,4780.0,13.3322,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1451,743220,3,1,,144207582,2406,Inconclusive,325495553.0,9971.0,61.8032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1452,743220,3,1,,144213236,2406,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1453,743220,3,1,,170465515,2406,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1454,743221,3,1,,144207582,2406,Active,,,27.6065,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1455,743221,3,1,,144213236,2406,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1456,743221,3,1,,170465515,2406,Inconclusive,,,2.6601,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1457,743222,3,1,,144207582,2406,Inconclusive,216409708.0,7421.0,21.9286,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1458,743222,3,1,,144213236,2406,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1459,743222,3,1,,170465515,2406,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1460,743223,3,1,,144207582,2406,Inconclusive,216409708.0,7421.0,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1461,743223,3,1,,144213236,2406,Inconclusive,216409708.0,7421.0,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1462,743223,3,1,,170465515,2406,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1463,743224,3,1,,144207582,2406,Active,,,21.9286,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1464,743224,3,1,,144213236,2406,Active,,,21.8724,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1465,743224,3,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1466,743225,3,1,,144207582,2406,Active,,,24.6043,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1467,743225,3,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1468,743225,3,1,,170465515,2406,Inconclusive,,,8.4852,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1469,743226,2,1,,144207582,2406,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1470,743226,2,1,,144213236,2406,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1471,743226,2,1,,170465515,2406,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1472,743227,2,1,,144207582,2406,Active,216409690.0,5467.0,43.7533,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1473,743227,2,1,,144213236,2406,Inconclusive,216409690.0,5467.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1474,743227,2,1,,170465515,2406,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1475,743228,3,1,,144207582,2406,Active,4504517.0,3315.0,44.7725,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1476,743228,3,1,,144213236,2406,Inconclusive,4504517.0,3315.0,54.941,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1477,743228,3,1,,170465515,2406,Inconclusive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1478,743239,2,1,,144207582,2406,Active,325495553.0,9971.0,38.9952,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1479,743239,2,1,,144213236,2406,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1480,743239,2,1,,170465515,2406,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1481,743240,2,1,,144207582,2406,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1482,743240,2,1,,144213236,2406,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1483,743240,2,1,,170465515,2406,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1484,743241,2,1,,144207582,2406,Inconclusive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1485,743241,2,1,,144213236,2406,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1486,743241,2,1,,170465515,2406,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1487,743242,2,1,,144207582,2406,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1488,743242,2,1,,144213236,2406,Inconclusive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1489,743242,2,1,,170465515,2406,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1490,743244,1,1,,144204383,2406,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1491,743288,1,1,,17389712,2406,Inconclusive,,,39.8107,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1492,743288,1,1,,26751444,2406,Inconclusive,,,70.7946,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1493,743292,1,1,,17389712,2406,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1494,743292,1,1,,26751444,2406,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1495,922792,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011127,Other,,
1496,922793,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011127,Other,,
1497,922794,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011127,Other,,
1498,922795,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011127,Other,,
1499,922796,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011127,Other,,
1500,922797,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011127,Other,,
1501,922798,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011127,Other,,
1502,922799,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011127,Other,,
1503,922800,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011127,Other,,
1504,922801,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011127,Other,,
1505,922802,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011127,Other,,
1506,922803,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011127,Other,,
1507,922804,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011127,Other,,
1508,922805,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011127",Other,,
1509,922806,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011127,Other,,
1510,922807,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011127,Other,,
1511,922808,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011127,Other,,
1512,922809,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011127,Other,,
1513,922810,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011127,Other,,
1514,922811,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011127,Other,,
1515,922812,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011127,Other,,
1516,922813,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011127,Other,,
1517,922814,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011127,Other,,
1518,923752,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011127,Other,,
1519,923753,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011127,Other,,
1520,923754,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011127,Other,,
1521,923755,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011127,Other,,
1522,923756,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011127,Other,,
1523,923757,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011127,Other,,
1524,923758,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011127,Other,,
1525,923759,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011127,Other,,
1526,923760,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011127,Other,,
1527,923761,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011127,Other,,
1528,923762,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011127,Other,,
1529,923763,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011127,Other,,
1530,923764,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011127,Other,,
1531,923765,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011127",Other,,
1532,923766,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011127,Other,,
1533,931162,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011127,Other,,
1534,931163,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011127,Other,,
1535,931164,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011127,Other,,
1536,931165,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011127,Other,,
1537,931166,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011127,Other,,
1538,931167,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011127,Other,,
1539,931168,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011127,Other,,
1540,931169,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011127",Other,,
1541,931170,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011127,Other,,
1542,931171,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011127,Other,,
1543,931172,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011127,Other,,
1544,931173,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011127,Other,,
1545,933818,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011127,Other,,
1546,933819,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011127,Other,,
1547,933820,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011127,Other,,
1548,933821,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011127,Other,,
1549,933822,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011127,Other,,
1550,933823,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011127,Other,,
1551,933824,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011127,Other,,
1552,940105,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011127,Other,,
1553,940106,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011127,Other,,
1554,940107,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011127,Other,,
1555,940108,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011127,Other,,
1556,940109,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011127,Other,,
1557,940110,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011127,Other,,
1558,940111,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011127,Other,,
1559,940112,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011127,Other,,
1560,940113,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011127,Other,,
1561,940114,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011127,Other,,
1562,940115,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011127",Other,,
1563,940116,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011127,Other,,
1564,940117,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011127,Other,,
1565,940118,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011127,Other,,
1566,940119,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011127,Other,,
1567,940120,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011127,Other,,
1568,940121,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011127,Other,,
1569,940122,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011127,Other,,
1570,940123,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011127,Other,,
1571,950534,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011127,Other,,
1572,950535,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011127,Other,,
1573,950536,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011127,Other,,
1574,950537,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011127,Other,,
1575,950538,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011127,Other,,
1576,950539,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011127,Other,,
1577,950540,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011127,Other,,
1578,950541,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011127,Other,,
1579,950542,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011127,Other,,
1580,950543,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011127,Other,,
1581,950544,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011127,Other,,
1582,950545,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011127,Other,,
1583,950546,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011127,Other,,
1584,950547,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011127,Other,,
1585,950548,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011127,Other,,
1586,950549,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011127,Other,,
1587,952728,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011127,Other,,
1588,954710,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011127,Other,,
1589,954711,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011127,Other,,
1590,954712,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011127,Other,,
1591,954713,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011127,Other,,
1592,954714,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011127,Other,,
1593,954715,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011127,Other,,
1594,954716,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011127,Other,,
1595,954717,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011127,Other,,
1596,954718,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011127,Other,,
1597,954719,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011127,Other,,
1598,954720,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011127,Other,,
1599,954721,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011127,Other,,
1600,954722,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011127,Other,,
1601,954723,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011127,Other,,
1602,954724,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011127,Other,,
1603,954725,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011127,Other,,
1604,954726,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011127,Other,,
1605,954727,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011127,Other,,
1606,954728,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011127,Other,,
1607,954729,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011127,Other,,
1608,954730,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011127,Other,,
1609,954731,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011127,Other,,
1610,954732,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011127,Other,,
1611,954733,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011127,Other,,
1612,954734,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011127,Other,,
1613,955322,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011127,Other,,
1614,955323,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011127,Other,,
1615,955324,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011127,Other,,
1616,955325,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011127,Other,,
1617,955326,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011127,Other,,
1618,955327,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011127,Other,,
1619,955328,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011127,Other,,
1620,955329,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011127,Other,,
1621,955330,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011127,Other,,
1622,955331,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011127,Other,,
1623,955332,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011127,Other,,
1624,955333,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011127,Other,,
1625,960910,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011127,Other,,
1626,960911,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011127,Other,,
1627,960912,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011127,Other,,
1628,963742,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011127,Other,,
1629,963743,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011127,Other,,
1630,963744,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011127,Other,,
1631,963745,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011127,Other,,
1632,963746,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011127,Other,,
1633,963747,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011127,Other,,
1634,963748,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011127,Other,,
1635,963749,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011127,Other,,
1636,963750,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011127,Other,,
1637,963751,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011127,Other,,
1638,963752,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011127,Other,,
1639,963753,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011127,Other,,
1640,963754,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011127,Other,,
1641,963755,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011127,Other,,
1642,963756,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011127,Other,,
1643,963757,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011127,Other,,
1644,963758,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011127,Other,,
1645,963759,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011127,Other,,
1646,963760,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011127,Other,,
1647,979652,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011127",Other,,
1648,979653,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S011127",Other,,
1649,980083,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S011127",Other,,
1650,980084,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S011127",Other,,
1651,980085,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1652,980086,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011127",Other,,
1653,980087,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S011127,Other,,
1654,980088,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S011127",Other,,
1655,980089,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S011127,Other,,
1656,980090,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S011127",Other,,
1657,980091,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S011127",Other,,
1658,980092,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S011127",Other,,
1659,980093,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S011127",Other,,
1660,980094,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1661,981607,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S011127",Other,,
1662,981608,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S011127",Other,,
1663,981609,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1664,981610,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011127",Other,,
1665,981611,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1666,981612,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1667,981613,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S011127",Other,,
1668,981614,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1669,981615,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1670,981616,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1671,981617,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S011127",Other,,
1672,981618,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1673,981619,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1674,981620,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S011127",Other,,
1675,981621,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1676,981622,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S011127,Other,,
1677,981623,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S011127,Other,,
1678,981624,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S011127",Other,,
1679,981625,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1680,981626,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S011127",Other,,
1681,981627,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S011127,Other,,
1682,981628,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1683,982095,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1684,982096,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1685,982097,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S011127",Other,,
1686,982098,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S011127,Other,,
1687,982099,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1688,982100,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S011127",Other,,
1689,982101,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S011127",Other,,
1690,982102,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1691,982103,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1692,982104,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S011127",Other,,
1693,982105,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S011127",Other,,
1694,982106,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S011127",Other,,
1695,982107,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S011127,Other,,
1696,982108,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S011127",Other,,
1697,982109,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S011127",Other,,
1698,982110,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S011127",Other,,
1699,982111,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S011127,Other,,
1700,982112,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1701,983631,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S011127",Other,,
1702,983632,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1703,983633,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1704,983634,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1705,983635,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S011127",Other,,
1706,992310,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011127",Other,,
1707,992311,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S011127",Other,,
1708,992312,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S011127",Other,,
1709,992313,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S011127",Other,,
1710,992314,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1711,992315,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011127",Other,,
1712,992316,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S011127,Other,,
1713,992317,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S011127",Other,,
1714,992318,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S011127,Other,,
1715,992319,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S011127",Other,,
1716,992320,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S011127",Other,,
1717,992321,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S011127",Other,,
1718,992322,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S011127",Other,,
1719,992323,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1720,992324,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1721,992325,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S011127",Other,,
1722,992326,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S011127",Other,,
1723,992327,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1724,992328,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1725,992329,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S011127",Other,,
1726,992330,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1727,992331,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1728,992332,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1729,992333,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S011127",Other,,
1730,992334,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1731,992335,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S011127",Other,,
1732,992336,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S011127",Other,,
1733,992337,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1734,992338,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Spleen; Assay: Extramedullary Hematopoiesis Increased; Study_ID: S011127,Other,,
1735,992339,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S011127,Other,,
1736,992919,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S011127,Other,,
1737,1003847,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S011127",Other,,
1738,1003848,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1739,1003849,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1740,1003850,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S011127",Other,,
1741,1003851,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S011127,Other,,
1742,1003852,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1743,1003853,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1744,1003854,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1745,1003855,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S011127",Other,,
1746,1003856,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S011127",Other,,
1747,1003857,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S011127,Other,,
1748,1003858,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011127",Other,,
1749,1003859,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S011127",Other,,
1750,1003860,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S011127",Other,,
1751,1003861,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S011127",Other,,
1752,1003862,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011127",Other,,
1753,1003863,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S011127",Other,,
1754,1003864,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S011127",Other,,
1755,1003865,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Spleen; Assay: Lymphoid Depletion; Study_ID: S011127,Other,,
1756,1003866,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S011127",Other,,
1757,1003867,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S011127,Other,,
1758,1003868,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S011127",Other,,
1759,1003869,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S011127",Other,,
1760,1003870,1,3,,103206701,2406,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S011127,Other,,
1761,1003871,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1762,1003872,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S011127",Other,,
1763,1003873,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S011127",Other,,
1764,1003874,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1765,1003875,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S011127",Other,,
1766,1003876,1,3,,103206701,2406,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % corn oil; Route: oral gavage | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S011127",Other,,
1767,1117298,1,2,,170465515,2406,Inactive,,,3.1623,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
1768,1117304,1,2,,170465515,2406,Active,,,11.2202,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
1769,1117305,1,2,,170465515,2406,Active,,,22.3872,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
1770,1117310,1,1,,170465515,2406,Inactive,,,3.16228,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
1771,1117312,1,1,,170465515,2406,Active,,,22.3872,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
1772,1117314,1,1,,170465515,2406,Inactive,,,11.2202,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
1773,1117319,1,2,,855531,2406,Inactive,9629361.0,155459.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1774,1117319,1,2,,855531,2406,Inactive,13399304.0,60489.0,,Average IC50,High Throughput Screen to Identify Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G:#A time-resolved fluorescence resonance energy transfer (TR-FRET) assay for HIV-1 Vif-APOBEC3G interaction,Confirmatory,,
1775,1117322,1,1,,170465515,2406,Active,,,0.001,IC50,RKO viability from Cell TiterGlo-IC50,Confirmatory,,
1776,1117323,1,1,,170465515,2406,Active,,,0.00867,IC50,SNU-C1 viability from Cell TiterGlo-IC50,Confirmatory,,
1777,1117324,1,1,,170465515,2406,Inactive,,,10.0,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
1778,1117325,1,1,,170465515,2406,Inactive,,,20.0,IC50,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
1779,1117326,1,1,,170465515,2406,Active,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1780,1117327,1,1,,170465515,2406,Inactive,,,20.0,IC50,alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
1781,1117328,1,1,,170465515,2406,Inactive,,,,,human p70S6K1 kinase inhibition-screen,Screening,,
1782,1117329,1,1,,170465515,2406,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1783,1117330,1,1,,170465515,2406,Active,,,0.9959,IC50,HT-29 viability from Cell TiterGlo-IC50,Confirmatory,,
1784,1117332,1,1,,170465515,2406,Active,,,0.001,IC50,HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1785,1117334,1,1,,170465515,2406,Active,,,0.01505,IC50,Colo320 viability from Cell TiterGlo-IC50,Confirmatory,,
1786,1117336,1,1,,170465515,2406,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1787,1117337,1,1,,170465515,2406,Active,,,1.7932,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
1788,1117338,1,1,,170465515,2406,Active,,,0.001,IC50,SW480 viability from Cell TiterGlo-IC50,Confirmatory,,
1789,1117339,1,1,,170465515,2406,Active,,,0.001,IC50,GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1790,1117340,1,1,,170465515,2406,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1791,1117341,1,1,,170465515,2406,Active,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1792,1117342,1,1,,170465515,2406,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1793,1117343,1,1,,170465515,2406,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1794,1117344,1,1,,170465515,2406,Inactive,,,19.4275,IC50,GLP1 secretion from NCI-H716 cells-IC50,Confirmatory,,
1795,1117345,1,1,,170465515,2406,Inactive,,,20.0,IC50,GLP1 secretion from STC-1 cells-IC50,Confirmatory,,
1796,1117346,1,1,,170465515,2406,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1797,1117347,1,1,,170465515,2406,Inactive,,,10.0,IC50,Decreased HeLa cell count-IC50,Confirmatory,,
1798,1117348,1,1,,170465515,2406,Inactive,,,10.0,IC50,Increased HeLa cells in S-phase-IC50,Confirmatory,,
1799,1117349,1,1,,170465515,2406,Inactive,,,10.0,IC50,Increased HeLa cells with 2N DNA content-IC50,Confirmatory,,
1800,1117350,1,1,,170465515,2406,Inactive,,,10.0,IC50,Increased chromatin condensation in HeLa cells-IC50,Confirmatory,,
1801,1117351,1,1,,170465515,2406,Inactive,,,10.0,IC50,Increased HeLa cells with 4N DNA content-IC50,Confirmatory,,
1802,1117352,1,1,,170465515,2406,Active,,,0.001,IC50,DLD-1 viability from Cell TiterGlo-IC50,Confirmatory,,
1803,1117353,1,1,,170465515,2406,Active,,,,,human KDR kinase inhibition-screen,Screening,,
1804,1117354,1,1,,170465515,2406,Inactive,,,,,human JAK2 kinase inhibition-screen,Screening,,
1805,1117355,1,1,,170465515,2406,Active,,,,,human GSK3B kinase inhibition-screen,Screening,,
1806,1117356,1,1,,170465515,2406,Inactive,,,,,human FLT3 kinase inhibition-screen,Screening,,
1807,1159509,1,1,,144207582,2406,Inconclusive,119626539.0,4790.0,55.0822,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1808,1159509,1,1,,144213236,2406,Inconclusive,119626539.0,4790.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1809,1159509,1,1,,170465515,2406,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1810,1159515,1,1,,144207582,2406,Active,,,55.0822,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1811,1159515,1,1,,144213236,2406,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1812,1159515,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1813,1159516,1,1,,144207582,2406,Inconclusive,119611100.0,22926.0,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1814,1159516,1,1,,144213236,2406,Inconclusive,119611100.0,22926.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1815,1159516,1,1,,170465515,2406,Inconclusive,119611100.0,22926.0,21.3138,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1816,1159517,1,1,,144207582,2406,Active,,,55.0822,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1817,1159517,1,1,,144213236,2406,Active,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1818,1159517,1,1,,170465515,2406,Inconclusive,,,11.9856,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1819,1159518,1,1,,144207582,2406,Inconclusive,119626539.0,4790.0,58.346000000000004,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1820,1159518,1,1,,144213236,2406,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1821,1159518,1,1,,170465515,2406,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1822,1159519,1,1,,144207582,2406,Inconclusive,119611100.0,22926.0,55.0822,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1823,1159519,1,1,,144213236,2406,Inconclusive,119611100.0,22926.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1824,1159519,1,1,,170465515,2406,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1825,1159520,1,1,,144207582,2406,Active,,,15.3865,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1826,1159520,1,1,,144213236,2406,Active,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1827,1159520,1,1,,170465515,2406,Inconclusive,,,9.4392,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1828,1159521,1,1,,144207582,2406,Active,15928672.0,19885.0,2.7362,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1829,1159521,1,1,,144213236,2406,Active,15928672.0,19885.0,5.4483,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1830,1159521,1,1,,170465515,2406,Active,15928672.0,19885.0,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1831,1159523,1,1,,144207582,2406,Active,15928672.0,19885.0,4.7549,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1832,1159523,1,1,,144213236,2406,Active,15928672.0,19885.0,5.44827,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1833,1159523,1,1,,170465515,2406,Inconclusive,15928672.0,19885.0,9.99848,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1834,1159525,1,1,,144207582,2406,Active,,,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1835,1159525,1,1,,144213236,2406,Active,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1836,1159525,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1837,1159526,1,1,,144207582,2406,Inconclusive,119627033.0,3725.0,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1838,1159526,1,1,,144213236,2406,Inconclusive,119627033.0,3725.0,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1839,1159526,1,1,,170465515,2406,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1840,1159527,1,1,,144207582,2406,Inconclusive,325495497.0,6256.0,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1841,1159527,1,1,,144213236,2406,Inconclusive,325495497.0,6256.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1842,1159527,1,1,,170465515,2406,Inconclusive,325495497.0,6256.0,3.0107,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1843,1159528,1,1,,144207582,2406,Inconclusive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1844,1159528,1,1,,144213236,2406,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1845,1159528,1,1,,170465515,2406,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1846,1159529,1,1,,144207582,2406,Active,,,49.0921,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1847,1159529,1,1,,144213236,2406,Inconclusive,,,48.9662,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1848,1159529,1,1,,170465515,2406,Inconclusive,,,2.3914,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1849,1159531,1,1,,144207582,2406,Inconclusive,325495497.0,6256.0,3.0975,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1850,1159531,1,1,,144213236,2406,Inconclusive,325495497.0,6256.0,2.45412,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1851,1159531,1,1,,170465515,2406,Inconclusive,325495497.0,6256.0,5.35378,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1852,1159551,1,1,,144207582,2406,Inconclusive,,,30.7002,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1853,1159551,1,1,,144213236,2406,Inconclusive,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1854,1159551,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1855,1159552,1,1,,144207582,2406,Active,325495463.0,5914.0,30.7002,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1856,1159552,1,1,,144213236,2406,Active,325495463.0,5914.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1857,1159552,1,1,,170465515,2406,Inconclusive,325495463.0,5914.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1858,1159553,2,1,,144207582,2406,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1859,1159553,2,1,,144213236,2406,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1860,1159553,2,1,,170465515,2406,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1861,1159555,1,1,,144207582,2406,Active,325495463.0,5914.0,36.4872,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1862,1159555,1,1,,144213236,2406,Active,325495463.0,5914.0,26.278000000000002,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1863,1159555,1,1,,170465515,2406,Active,325495463.0,5914.0,28.7255,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1864,1159607,2,1,,312996210,2406,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1865,1159610,1,1,,165230484,2406,Inactive,,,,,Confirmed Potentiators of KCNQ2 Potassium Channel,Other,,
1866,1159614,1,2,,170465515,2406,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1867,1215087,1,2,,103206701,2406,Active,6093860.0,8856.0,12.6,EC50,Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis,Confirmatory,20966043.0,
1868,1215089,1,2,,103206701,2406,Unspecified,6093860.0,8856.0,,,Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 after 24 hrs by luminescent analysis relative to rifampicin,Other,20966043.0,
1869,1215091,1,2,,103206701,2406,Unspecified,6093860.0,8856.0,,,Activation of human PXR expressed in human HepG2 (DPX-2) cells up to 46 uM after 24 hrs by luciferase reporter gene based luminescent analysis,Other,20966043.0,
1870,1215093,1,2,,103206701,2406,Unspecified,10720242.0,84385.0,,,Activation of rat PXR expressed in human HepG2 cells up to 46 uM after 24 hrs by luciferase reporter gene based luminescent analysis,Other,20966043.0,
1871,1215094,1,2,,103206701,2406,Active,6093860.0,8856.0,1.0,EC50,Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay,Confirmatory,20966043.0,
1872,1215095,1,2,,103206701,2406,Unspecified,6093860.0,8856.0,,,Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay relative to SR12813,Other,20966043.0,
1873,1224834,3,1,,144207582,2406,Active,,,21.7341,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1874,1224834,3,1,,144213236,2406,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1875,1224834,3,1,,170465515,2406,Inconclusive,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1876,1224835,1,1,,144207582,2406,Inconclusive,160794.0,,89.5771,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1877,1224835,1,1,,144213236,2406,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1878,1224835,1,1,,170465515,2406,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1879,1224836,1,1,,144207582,2406,Inconclusive,,,13.7133,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1880,1224836,1,1,,144213236,2406,Inconclusive,,,21.6899,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1881,1224836,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1882,1224837,1,1,,144207582,2406,Inconclusive,,,15.3865,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1883,1224837,1,1,,144213236,2406,Inconclusive,,,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1884,1224837,1,1,,170465515,2406,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1885,1224838,1,1,,144207582,2406,Active,66775687.0,9970.0,17.264,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1886,1224838,1,1,,144213236,2406,Inconclusive,66775687.0,9970.0,27.305999999999997,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1887,1224838,1,1,,170465515,2406,Inconclusive,66775687.0,9970.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1888,1224839,1,1,,144207582,2406,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1889,1224839,1,1,,144213236,2406,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1890,1224839,1,1,,170465515,2406,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1891,1224840,3,1,,144207582,2406,Inconclusive,,,15.3865,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1892,1224840,3,1,,144213236,2406,Inconclusive,,,19.3312,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1893,1224840,3,1,,170465515,2406,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1894,1224841,3,1,,144207582,2406,Active,325495545.0,2101.0,4.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1895,1224841,3,1,,144213236,2406,Active,325495545.0,2101.0,10.8707,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1896,1224841,3,1,,170465515,2406,Active,325495545.0,2101.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1897,1224842,3,1,,144207582,2406,Inactive,325495545.0,2101.0,3.8649,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1898,1224842,3,1,,144213236,2406,Inactive,325495545.0,2101.0,10.8707,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1899,1224842,3,1,,170465515,2406,Inactive,325495545.0,2101.0,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1900,1224843,1,1,,144207582,2406,Inconclusive,119601739.0,7253.0,54.5935,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1901,1224843,1,1,,144213236,2406,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1902,1224843,1,1,,170465515,2406,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1903,1224844,1,1,,144207582,2406,Active,,,19.5439,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1904,1224844,1,1,,144213236,2406,Active,,,24.5412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1905,1224844,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1906,1224845,1,1,,144207582,2406,Inconclusive,344243002.0,100757539.0,89.9813,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1907,1224845,1,1,,144213236,2406,Inconclusive,344243002.0,100757539.0,89.7625,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1908,1224845,1,1,,170465515,2406,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1909,1224846,1,1,,144207582,2406,Inconclusive,11995455.0,3091.0,24.6043,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1910,1224846,1,1,,144213236,2406,Inconclusive,11995455.0,3091.0,43.6412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1911,1224846,1,1,,170465515,2406,Inconclusive,11995455.0,3091.0,9.5205,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1912,1224847,1,1,,144207582,2406,Active,,,28.4546,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1913,1224847,1,1,,144213236,2406,Active,,,44.9878,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1914,1224847,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1915,1224848,3,1,,144207582,2406,Active,325495545.0,2101.0,5.4594,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1916,1224848,3,1,,144213236,2406,Active,325495545.0,2101.0,9.6885,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1917,1224848,3,1,,170465515,2406,Active,325495545.0,2101.0,18.8336,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1918,1224849,3,1,,144207582,2406,Inactive,325495545.0,2101.0,5.4594,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1919,1224849,3,1,,144213236,2406,Inactive,325495545.0,2101.0,9.6885,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1920,1224849,3,1,,170465515,2406,Inactive,325495545.0,2101.0,18.8336,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1921,1224857,2,1,,170465515,2406,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1922,1224859,2,1,,170465515,2406,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1923,1224867,1,1,,144207582,2406,Inconclusive,,,55.0822,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1924,1224867,1,1,,144213236,2406,Inconclusive,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1925,1224867,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1926,1224868,1,1,,144207582,2406,Active,,,19.5439,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1927,1224868,1,1,,144213236,2406,Active,,,15.4845,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1928,1224868,1,1,,170465515,2406,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1929,1224869,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1930,1224869,1,1,,144213236,2406,Active,,,27.5357,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1931,1224869,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1932,1224870,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1933,1224870,1,1,,144213236,2406,Inconclusive,,,43.6412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1934,1224870,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1935,1224871,1,1,,144207582,2406,Active,,,49.0921,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1936,1224871,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1937,1224871,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1938,1224872,1,1,,144207582,2406,Inconclusive,,,38.9952,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1939,1224872,1,1,,144213236,2406,Inconclusive,,,24.5412,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1940,1224872,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1941,1224873,1,1,,144207582,2406,Inconclusive,,,43.7533,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1942,1224873,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1943,1224873,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1944,1224874,1,1,,144207582,2406,Active,,,17.4185,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1945,1224874,1,1,,144213236,2406,Active,,,13.8006,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1946,1224874,1,1,,170465515,2406,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1947,1224875,1,1,,144207582,2406,Active,,,43.7533,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1948,1224875,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1949,1224875,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1950,1224876,1,1,,144207582,2406,Inconclusive,,,61.8032,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1951,1224876,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1952,1224876,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1953,1224877,1,1,,144207582,2406,Inconclusive,,,61.8032,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1954,1224877,1,1,,144213236,2406,Inconclusive,,,27.5357,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1955,1224877,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1956,1224878,1,1,,144207582,2406,Inconclusive,,,55.0822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1957,1224878,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1958,1224878,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1959,1224879,1,1,,144207582,2406,Active,,,55.0822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1960,1224879,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1961,1224879,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1962,1224880,1,1,,144207582,2406,Inconclusive,,,21.9286,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1963,1224880,1,1,,144213236,2406,Inconclusive,,,34.6654,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1964,1224880,1,1,,170465515,2406,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1965,1224881,1,1,,144207582,2406,Active,,,49.0921,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1966,1224881,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1967,1224881,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1968,1224882,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1969,1224882,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1970,1224882,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1971,1224883,1,1,,144207582,2406,Inconclusive,,,27.6065,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1972,1224883,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1973,1224883,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1974,1224884,1,1,,144207582,2406,Inconclusive,,,55.0822,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1975,1224884,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1976,1224884,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1977,1224885,1,1,,144207582,2406,Inconclusive,,,38.9952,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1978,1224885,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1979,1224885,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1980,1224886,1,1,,144207582,2406,Active,,,21.9286,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1981,1224886,1,1,,144213236,2406,Inconclusive,,,19.4938,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1982,1224886,1,1,,170465515,2406,Inconclusive,,,26.8325,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1983,1224887,1,1,,144207582,2406,Inconclusive,,,27.6065,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1984,1224887,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1985,1224887,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1986,1224888,1,1,,144207582,2406,Inconclusive,,,38.9952,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1987,1224888,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1988,1224888,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1989,1224889,1,1,,144207582,2406,Inconclusive,,,34.7545,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1990,1224889,1,1,,144213236,2406,Inconclusive,,,38.8952,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1991,1224889,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1992,1224890,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1993,1224890,1,1,,144213236,2406,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1994,1224890,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1995,1224892,1,1,,144207582,2406,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1996,1224892,1,1,,144213236,2406,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1997,1224892,1,1,,170465515,2406,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1998,1224893,1,1,,144207582,2406,Inconclusive,66775687.0,9970.0,21.1174,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1999,1224893,1,1,,144213236,2406,Inconclusive,66775687.0,9970.0,27.305999999999997,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2000,1224893,1,1,,170465515,2406,Inconclusive,66775687.0,9970.0,33.4915,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2001,1224894,1,1,,144207582,2406,Inconclusive,11995455.0,3091.0,53.0084,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2002,1224894,1,1,,144213236,2406,Inconclusive,11995455.0,3091.0,54.941,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2003,1224894,1,1,,170465515,2406,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2004,1224895,1,1,,144207582,2406,Inconclusive,119601739.0,7253.0,64.1418,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2005,1224895,1,1,,144213236,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2006,1224895,1,1,,170465515,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2007,1224896,1,1,,144207582,2406,Inconclusive,344243002.0,100757539.0,89.9813,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2008,1224896,1,1,,144213236,2406,Inconclusive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2009,1224896,1,1,,170465515,2406,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2010,1224923,1,1,,103206701,2406,Active,,,,,Summary of drugs withdrawn.,Other,,
2011,1259241,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2012,1259241,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2013,1259241,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2014,1259242,1,1,,144207582,2406,Inconclusive,,,13.7133,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2015,1259242,1,1,,144213236,2406,Inconclusive,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2016,1259242,1,1,,170465515,2406,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2017,1259243,1,1,,144207582,2406,Active,124375976.0,367.0,6.1255,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2018,1259243,1,1,,144213236,2406,Active,124375976.0,367.0,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2019,1259243,1,1,,170465515,2406,Active,124375976.0,367.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2020,1259244,1,1,,144207582,2406,Active,348019627.0,2099.0,12.222000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2021,1259244,1,1,,144213236,2406,Active,348019627.0,2099.0,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2022,1259244,1,1,,170465515,2406,Inconclusive,348019627.0,2099.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2023,1259247,1,1,,144207582,2406,Inconclusive,124375976.0,367.0,11.7618,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2024,1259247,1,1,,144213236,2406,Inconclusive,124375976.0,367.0,11.296,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2025,1259247,1,1,,170465515,2406,Inconclusive,124375976.0,367.0,26.6032,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2026,1259248,1,1,,144207582,2406,Active,348019627.0,2099.0,12.4587,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2027,1259248,1,1,,144213236,2406,Active,348019627.0,2099.0,13.6854,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2028,1259248,1,1,,170465515,2406,Active,348019627.0,2099.0,26.6032,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2029,1259332,1,1,,855531,2406,Active,,,7.67,AC50_uM,7124-01: Inhibition of CD40 signaling in B cell lineage,Other,,
2030,1259333,1,1,,855531,2406,Inactive,,,,AC50_uM,"7124-04: Celltiter Glo, Cytotoxicity assay",Other,,
2031,1259334,1,1,,855531,2406,Active,,,3.41,AC50_uM,"7124-02: inhibition of TNFa signaling in B cell lineage, counterscreen",Other,,
2032,1259344,1,1,,144204383,2406,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
2033,1259355,1,1,,26751444,2406,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
2034,1259356,1,1,,144204383,2406,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
2035,1259364,1,1,,144207582,2406,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2036,1259364,1,1,,144213236,2406,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2037,1259364,1,1,,170465515,2406,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2038,1259365,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2039,1259365,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2040,1259365,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2041,1259366,1,1,,144207582,2406,Inconclusive,,,38.6492,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2042,1259366,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2043,1259366,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2044,1259367,1,1,,144207582,2406,Active,,,27.3616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2045,1259367,1,1,,144213236,2406,Inconclusive,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2046,1259367,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2047,1259368,1,1,,144207582,2406,Inactive,109731339.0,2737.0,15.3865,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2048,1259368,1,1,,144213236,2406,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2049,1259368,1,1,,170465515,2406,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2050,1259369,1,1,,144207582,2406,Active,109731339.0,2737.0,4.3365,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2051,1259369,1,1,,144213236,2406,Active,109731339.0,2737.0,15.3553,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2052,1259369,1,1,,170465515,2406,Active,109731339.0,2737.0,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2053,1259377,1,1,,144207582,2406,Inconclusive,54288833.0,2100.0,77.1154,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2054,1259377,1,1,,144213236,2406,Inconclusive,54288833.0,2100.0,12.1972,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2055,1259377,1,1,,170465515,2406,Inconclusive,54288833.0,2100.0,13.3332,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2056,1259378,1,1,,144207582,2406,Inconclusive,54288833.0,2100.0,77.1154,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2057,1259378,1,1,,144213236,2406,Active,54288833.0,2100.0,7.6959,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2058,1259378,1,1,,170465515,2406,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2059,1259379,1,1,,144207582,2406,Active,,,17.264,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2060,1259379,1,1,,144213236,2406,Active,,,24.3365,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2061,1259379,1,1,,170465515,2406,Active,,,26.6032,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2062,1259380,1,1,,144207582,2406,Active,,,54.5935,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2063,1259380,1,1,,144213236,2406,Active,,,61.1306,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2064,1259380,1,1,,170465515,2406,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2065,1259381,1,1,,144207582,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2066,1259381,1,1,,144213236,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2067,1259381,1,1,,170465515,2406,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2068,1259382,1,1,,144207582,2406,Active,,,30.7002,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2069,1259382,1,1,,144213236,2406,Active,,,54.4827,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2070,1259382,1,1,,170465515,2406,Inconclusive,,,11.8832,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2071,1259383,1,1,,144207582,2406,Inactive,348019627.0,2099.0,27.3616,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2072,1259383,1,1,,144213236,2406,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2073,1259383,1,1,,170465515,2406,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2074,1259384,1,1,,144207582,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2075,1259384,1,1,,144213236,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2076,1259384,1,1,,170465515,2406,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2077,1259385,1,1,,144207582,2406,Inconclusive,119601739.0,7253.0,68.7291,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2078,1259385,1,1,,144213236,2406,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2079,1259385,1,1,,170465515,2406,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2080,1259386,1,1,,144207582,2406,Inconclusive,,,13.7133,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2081,1259386,1,1,,144213236,2406,Inconclusive,,,17.2289,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2082,1259386,1,1,,170465515,2406,Inconclusive,,,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2083,1259387,1,1,,144207582,2406,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2084,1259387,1,1,,144213236,2406,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2085,1259387,1,1,,170465515,2406,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2086,1259388,1,1,,144207582,2406,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2087,1259388,1,1,,144213236,2406,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2088,1259388,1,1,,170465515,2406,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2089,1259390,1,1,,144207582,2406,Inconclusive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2090,1259390,1,1,,144213236,2406,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2091,1259390,1,1,,170465515,2406,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2092,1259391,1,1,,144207582,2406,Inconclusive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2093,1259391,1,1,,144213236,2406,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2094,1259391,1,1,,170465515,2406,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2095,1259392,1,1,,144207582,2406,Active,109731339.0,2737.0,9.34274,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2096,1259392,1,1,,144213236,2406,Inconclusive,109731339.0,2737.0,15.956,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2097,1259392,1,1,,170465515,2406,Active,109731339.0,2737.0,25.1151,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2098,1259393,1,1,,144207582,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2099,1259393,1,1,,144213236,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2100,1259393,1,1,,170465515,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2101,1259394,1,1,,144207582,2406,Inconclusive,54288833.0,2100.0,77.1154,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2102,1259394,1,1,,144213236,2406,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2103,1259394,1,1,,170465515,2406,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2104,1259395,1,1,,144207582,2406,Active,119601739.0,7253.0,61.2549,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2105,1259395,1,1,,144213236,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2106,1259395,1,1,,170465515,2406,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2107,1259396,1,1,,144207582,2406,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2108,1259396,1,1,,144213236,2406,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2109,1259396,1,1,,170465515,2406,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2110,1259400,1,1,,170465515,2406,Inconclusive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
2111,1259401,1,1,,144207582,2406,Inconclusive,325495545.0,2101.0,7.1418,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2112,1259401,1,1,,144213236,2406,Inconclusive,325495545.0,2101.0,10.0676,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2113,1259401,1,1,,170465515,2406,Active,325495545.0,2101.0,20.3361,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2114,1259402,1,1,,144207582,2406,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2115,1259402,1,1,,144213236,2406,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2116,1259402,1,1,,170465515,2406,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2117,1259403,1,1,,144207582,2406,Inconclusive,325495545.0,2101.0,6.74229,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2118,1259403,1,1,,144213236,2406,Inconclusive,325495545.0,2101.0,8.30982,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2119,1259403,1,1,,170465515,2406,Inconclusive,325495545.0,2101.0,22.8175,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2120,1259404,1,1,,144207582,2406,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2121,1259404,1,1,,144213236,2406,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2122,1259404,1,1,,170465515,2406,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2123,1259407,1,1,,363899993,2406,Inactive,,,,,CCRIS mutagenicity studies,Other,,
2124,1259408,1,1,,363895196,2406,Unspecified,,,,,GENE-TOX mutagenicity studies,Other,,
2125,1259416,1,2,,340087750,2406,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2126,1259416,1,2,,375178424,2406,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
2127,1259421,1,1,,340087750,2406,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2128,1259421,1,1,,375178424,2406,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
2129,1259423,1,2,,354919473,2406,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
2130,1259423,1,2,,354934346,2406,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
